var title_f23_55_24432="Occult supracondylar and radius fractures";
var content_f23_55_24432=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Occult ipsilateral fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 380px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Type II supracondylar fracture (white arrow) with an occult distal radial fracture (black arrows). B) Type II supracondylar fracture (white arrows) with an occult proximal humeral fracture (black arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kasser JR, Beaty JH. Supracondylar fractures of the distal humerus. In: Rockwood and Wilkins' Fractures in Children, 5th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24432=[""].join("\n");
var outline_f23_55_24432=null;
var title_f23_55_24433="Urticaria 3";
var content_f23_55_24433=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F63644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F63644&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Urticaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 276px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dermal vasodilatation occurs, with no epidermal change (scale).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24433=[""].join("\n");
var outline_f23_55_24433=null;
var title_f23_55_24434="Cranial nerve lymphoma";
var content_f23_55_24434=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69226&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69226&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cranial nerve involvement by non-Hodgkin's lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 452px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gadolinium enhancement of the seventh cranial nerve (arrow) in this axial T1 MRI is highly suggestive of lymphomatous involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24434=[""].join("\n");
var outline_f23_55_24434=null;
var title_f23_55_24435="Patient information: Stroke (The Basics)";
var content_f23_55_24435=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15328\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/2/21542\">",
"         Signs of stroke",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?25/42/26274\">",
"         Patient information: Arteriovenous malformations in the brain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/32/20994\">",
"         Patient information: Atrial fibrillation (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/34/22050\">",
"         Patient information: Hemorrhagic stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?10/48/11011\">",
"         Patient information: High cholesterol (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?38/40/39554\">",
"         Patient information: Lowering the risk of having another stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/37/36435\">",
"         Patient information: Medicines after an ischemic stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/45/3795\">",
"         Patient information: Recovery after stroke (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?34/22/35170\">",
"         Patient information: Transient ischemic attack (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?32/2/32803\">",
"         Patient information: What can go wrong after a heart attack? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?40/13/41168\">",
"         Patient information: Bell's palsy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/63/8180\">",
"         Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/53/19286\">",
"         Patient information: Ischemic stroke treatment (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/37/38484\">",
"         Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?20/18/20772\">",
"         Patient information: Transient ischemic attack (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Stroke (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/stroke-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H23723355\">",
"      <span class=\"h1\">",
"       What is a stroke?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Stroke is the term doctors use when a part of the brain dies because it goes without blood for too long. Strokes can happen when the blood supply to a part of the brain is cut off, because:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        An artery in the brain gets clogged or closes off, or",
"       </li>",
"       <li>",
"        An artery in the brain starts bleeding.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23723363\">",
"      <span class=\"h1\">",
"       How do strokes affect people?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The effects of a stroke depend on a lot of things, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Which part and how much of the brain is affected",
"       </li>",
"       <li>",
"        How quickly the stroke is treated",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people who have a stroke have no lasting effects. Others lose important brain functions. For example, some people become partly paralyzed or unable to speak. Stroke is one of the leading causes of death and disability in the United States.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23723370\">",
"      <span class=\"h1\">",
"       How can you tell if someone is having a stroke?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There is an easy way to remember the signs of a stroke. Just think of the word &ldquo;FAST&rdquo; (",
"      <a class=\"graphic graphic_figure graphicRef73487 \" href=\"UTD.htm?21/2/21542\">",
"       figure 1",
"      </a>",
"      ). Each letter in the word stands for one of the things you should watch for:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        <strong>",
"         F",
"        </strong>",
"        ace &mdash; Does the person&rsquo;s face look uneven or droop on one side?",
"       </li>",
"       <li>",
"        <strong>",
"         A",
"        </strong>",
"        rm &mdash; Does the person have weakness or numbness in one or both arms? Does one arm drift down if the person tries to hold both arms out?",
"       </li>",
"       <li>",
"        <strong>",
"         S",
"        </strong>",
"        peech &mdash; Is the person having trouble speaking? Does his or her speech sound strange?",
"       </li>",
"       <li>",
"        <strong>",
"         T",
"        </strong>",
"        ime &mdash; If you notice",
"        <strong>",
"         any",
"        </strong>",
"        of these stroke signs, call 9-1-1. You need to act FAST. The sooner treatment begins, the better the chances of recovery.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23723377\">",
"      <span class=\"h1\">",
"       How are strokes treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The right treatment depends on what kind of stroke you are having. To figure this out, you need to get to the hospital quickly.",
"     </p>",
"     <p>",
"      People whose strokes are caused by clogged arteries can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Get medicines that break up blood clots. These medicines can help reopen clogged arteries.",
"       </li>",
"       <li>",
"        Get medicines that prevent new blood clots. These medicines also help prevent future strokes.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      People whose strokes are caused by bleeding can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have treatments that reduce the damage caused by bleeding in or around the brain",
"       </li>",
"       <li>",
"        Stop taking medicines that increase bleeding, or take a lower dose",
"       </li>",
"       <li>",
"        Have surgery to repair the artery or stop the bleeding (this is not always possible to do)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23723384\">",
"      <span class=\"h1\">",
"       Can strokes be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To lower your risk of stroke, you should:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Lower your blood pressure, if it is high",
"       </li>",
"       <li>",
"        Keep your blood sugar as close to normal as possible, if you have diabetes",
"       </li>",
"       <li>",
"        Lower your cholesterol, if it is high",
"       </li>",
"       <li>",
"        Stop smoking, if you smoke",
"       </li>",
"       <li>",
"        Do something active for at least 30 minutes a day on most days of the week",
"       </li>",
"       <li>",
"        Lose weight, if you are overweight",
"       </li>",
"       <li>",
"        Eat a diet rich in fruits, vegetables, and low-fat dairy products, and low in meats, sweets, and refined grains (such as white bread or white rice)",
"       </li>",
"       <li>",
"        Eat less salt (sodium)",
"       </li>",
"       <li>",
"        Limit the amount of alcohol you drink",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        If you are a woman, do not drink more than 1 drink a day",
"       </li>",
"       <li>",
"        If you are a man, do not drink more than 2 drinks a day",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Take your medicines exactly as directed. Medicines that are especially important in preventing strokes include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Blood pressure medicines",
"       </li>",
"       <li>",
"        Medicines to prevent blood clots, such as daily",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?6/12/6342?source=see_link\">",
"         aspirin",
"        </a>",
"        ,",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"         warfarin",
"        </a>",
"        (brand name: Coumadin&reg;), and",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?0/58/933?source=see_link\">",
"         dabigatran",
"        </a>",
"        (brand name: Pradaxa&reg;)",
"       </li>",
"       <li>",
"        Medicines called statins, which lower cholesterol",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Another way to prevent strokes is to have surgery to reopen clogged arteries in the neck. This surgery is appropriate for only a small group of people.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23723391\">",
"      <span class=\"h1\">",
"       What is a &ldquo;TIA&rdquo;?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A TIA is like a stroke, but it does not damage the brain. TIAs happen when an artery in the brain gets clogged or closes off and then reopens on its own. This can happen if a blood clot forms and then moves away or dissolves. TIA stands for &ldquo;transient ischemic attack.&rdquo;",
"     </p>",
"     <p>",
"      Even though TIAs do not cause lasting symptoms, they are serious. If you have a TIA, you are at high risk of having a stroke. It's important that you see a doctor and take steps to prevent that from happening. Do not ignore the symptoms of a stroke even if they go away!",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H23723482\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?34/22/35170?source=see_link\">",
"       Patient information: Transient ischemic attack (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/40/39554?source=see_link\">",
"       Patient information: Lowering the risk of having another stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/37/36435?source=see_link\">",
"       Patient information: Medicines after an ischemic stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/45/3795?source=see_link\">",
"       Patient information: Recovery after stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/34/22050?source=see_link\">",
"       Patient information: Hemorrhagic stroke (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/48/11011?source=see_link\">",
"       Patient information: High cholesterol (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/32/20994?source=see_link\">",
"       Patient information: Atrial fibrillation (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/2/32803?source=see_link\">",
"       Patient information: What can go wrong after a heart attack? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/42/26274?source=see_link\">",
"       Patient information: Arteriovenous malformations in the brain (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=see_link\">",
"       Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?18/53/19286?source=see_link\">",
"       Patient information: Ischemic stroke treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/63/8180?source=see_link\">",
"       Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?20/18/20772?source=see_link\">",
"       Patient information: Transient ischemic attack (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/13/41168?source=see_link\">",
"       Patient information: Bell's palsy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?23/55/24435?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15328 Version 4.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-115.25.216.6-C9F66847B9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24435=[""].join("\n");
var outline_f23_55_24435=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723355\">",
"      What is a stroke?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723363\">",
"      How do strokes affect people?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723370\">",
"      How can you tell if someone is having a stroke?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723377\">",
"      How are strokes treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723384\">",
"      Can strokes be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723391\">",
"      What is a &ldquo;TIA&rdquo;?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23723482\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15328\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/2/21542\">",
"      Signs of stroke",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/42/26274?source=related_link\">",
"      Patient information: Arteriovenous malformations in the brain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/32/20994?source=related_link\">",
"      Patient information: Atrial fibrillation (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/13/41168?source=related_link\">",
"      Patient information: Bell's palsy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/34/22050?source=related_link\">",
"      Patient information: Hemorrhagic stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/63/8180?source=related_link\">",
"      Patient information: Hemorrhagic stroke treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/48/11011?source=related_link\">",
"      Patient information: High cholesterol (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?18/53/19286?source=related_link\">",
"      Patient information: Ischemic stroke treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/40/39554?source=related_link\">",
"      Patient information: Lowering the risk of having another stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/37/36435?source=related_link\">",
"      Patient information: Medicines after an ischemic stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/45/3795?source=related_link\">",
"      Patient information: Recovery after stroke (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=related_link\">",
"      Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?20/18/20772?source=related_link\">",
"      Patient information: Transient ischemic attack (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?34/22/35170?source=related_link\">",
"      Patient information: Transient ischemic attack (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/2/32803?source=related_link\">",
"      Patient information: What can go wrong after a heart attack? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_55_24436="Injection superior trochanter";
var content_f23_55_24436=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F57328&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F57328&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    Injection at the superior trochanter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 342px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A local anesthetic block placed just under the gluteus medius tendon and just short of the periosteum of the superior aspect of the trochanteric process can be used to confirm the presence of bursitis of the deeper trochanteric or gluteus medius bursa. The patient is placed in the lateral decubitus position with the affected side up and the knees flexed to 90&ordm;. The superior, posterior, and anterior edges of the trochanteric process are palpated and marked. The point of entry for injection of the superficial bursa is approximately 2 to 2.5 cm (0.75 to 1 in)&nbsp;above the midpoint of the most superior portion of the trochanter. Topical anesthetic (eg, ethyl chloride) is&nbsp;applied to&nbsp;the skin. Local anesthetic is placed at the gluteus medius tissue plane (1 mL) and at the periosteum of the femur (0.5 to 1 mL). A&nbsp;4 cm (1.5&nbsp;in), 22-gauge or 22-gauge spinal needle is inserted at a 45&ordm; angle in direct alignment with the femur; the depth is 2.5 to 6.4 cm (1 to 2.5 in)&nbsp;to the gluteus medius tendon, and 4 to 7.5 cm (1.5 to 3 in)&nbsp;to the superior trochanter. The needle is held lightly and advanced through the low resistance of the subcutaneous fat to the firm, rubbery resistance of the gluteus medius tissue plane. Following anesthesia at this level, the needle is advanced with firm pressure approximately 1.3 cm (0.5 in) farther to the periosteum of the femur. The patient will usually experience sharp pain as the needle touches the periosteum. Injection at this deeper level requires firm pressure. The needle should be rotated 180&ordm; or withdrawn slightly if excessive pressure is encountered. If the trochanter tenderness is significantly relieved with anesthetic injection, 1 mL of triamcinolone acetonide 40 mg/mL can be injected through the same needle.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24436=[""].join("\n");
var outline_f23_55_24436=null;
var title_f23_55_24437="Flow cytometry FL";
var content_f23_55_24437=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85884&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 614px\">",
"   <div class=\"ttl\">",
"    Flow cytometry follicular lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 594px; height: 388px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flow cytometric histograms show dual staining of CD10 and CD19, as well as CD20 and bcl-2. A monoclonal &kappa; pattern, positive FMC-7, and partial positive CD23 are also demonstrated. A small percentage of T cells are also present in the gated population, as represented by the CD5-positive and bcl-2-positive/CD20-negative clusters.",
"    <div class=\"footnotes\">",
"     SS: side scatter; PC5: phycoerythrin-cyanin 5; PE: phycoerythrin; ECD: phycoerythrin-Texas Red; FITC: fluorescein isothiocyanate.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sun T. Flow Cytometry, Immunohistochemistry, and Molecular Genetics for Hematologic Neoplasms, 2nd ed, Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24437=[""].join("\n");
var outline_f23_55_24437=null;
var title_f23_55_24438="Widow spiderlings";
var content_f23_55_24438=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F65792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F65792&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Western black widow spiderlings",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard S Vetter, MS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24438=[""].join("\n");
var outline_f23_55_24438=null;
var title_f23_55_24439="Lymph nodes body PI";
var content_f23_55_24439=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F64350&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F64350&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 579px\">",
"   <div class=\"ttl\">",
"    Lymph node groups",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 559px; height: 574px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure shows the lymph node groups and sub-areas.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Celigny, P, Roy, P, Colombat, P, et al. Follicular lymphoma international prognostic index. Blood 2004; 104:1258. Copyright &copy; 2004. American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24439=[""].join("\n");
var outline_f23_55_24439=null;
var title_f23_55_24440="The common cold in adults: Diagnosis and clinical features";
var content_f23_55_24440=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   The common cold in adults: Diagnosis and clinical features",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Micah T McClain, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Mark D Aronson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24440/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/55/24440/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The common cold is a benign self-limited syndrome representing a group of diseases caused by members of several families of viruses. It is the most frequent acute illness in the United States and throughout the industrialized world [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"     1",
"    </a>",
"    ]. The term \"common cold\" refers to a mild upper respiratory viral illness involving, to variable degrees, sneezing, nasal congestion and discharge (rhinorrhea), sore throat, cough, low grade fever, headache, and malaise. The common cold is a separate and distinctly different entity than influenza, pharyngitis, acute bronchitis, acute bacterial rhinosinusitis, allergic rhinitis, and pertussis.",
"   </p>",
"   <p>",
"    The common cold is associated with an enormous economic burden as assessed by lost productivity and expenditures for treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/2\">",
"     2",
"    </a>",
"    ]. A US telephone survey conducted between 2000 and 2001 indicates that about 500 million non-influenza viral respiratory infections occur yearly, resulting in estimated direct costs of $17 billion and indirect costs of $22.5 billion annually [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The average incidence of the common cold is five to seven episodes per year in preschool children, and two to three per year by adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/4\">",
"     4",
"    </a>",
"    ]. Annual absences from school and work in the United States due to colds caused 26 and 23 million lost days, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/2\">",
"     2",
"    </a>",
"    ]. Colds account for 40 percent of all time lost from jobs among employed people [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"     1",
"    </a>",
"    ]. It is no surprise then, that tens of millions of research dollars have been spent on ways to prevent and shorten the course of the common cold. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=see_link\">",
"     \"The common cold in children: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13146?source=see_link\">",
"     \"The common cold in children: Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The epidemiology and clinical manifestations of the common cold are discussed here. Treatment and prevention of colds are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=see_link\">",
"     \"The common cold in adults: Treatment and prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VIROLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 200 subtypes of viruses have been associated with the common cold. New viruses, such as the human metapneumovirus and bocaviruses, have been identified using PCR and Virochip technology, and it is anticipated that additional viruses that also cause the common cold are yet to be identified.",
"   </p>",
"   <p>",
"    Rhinoviruses, which include more than 100 serotypes, are the most common viruses associated with cold symptoms, and collectively cause 30 to 50 percent of colds. Coronaviruses cause about 10 to 15 percent of common colds. Viruses with marked seasonal variation, such as influenza and parainfluenza, typically cause more systemic symptoms than other cold viruses; however, they also cause illnesses compatible with the common cold. Influenza virus causes about 5 to 15 percent of colds, and respiratory syncytial virus (RSV) and parainfluenza virus are each responsible for about 5 percent (",
"    <a class=\"graphic graphic_table graphicRef79871 \" href=\"UTD.htm?20/35/21051\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link\">",
"     \"Clinical manifestations of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5528?source=see_link\">",
"     \"Diagnosis of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/38/617?source=see_link\">",
"     \"Parainfluenza viruses in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Adenoviruses and enteroviruses have also been associated with the common cold. Adenovirus more commonly causes pharyngitis and fever than cold symptoms, and may also cause epidemics of lower respiratory infections in military quarters, as well as severe lower respiratory infections in immunocompromised patients. Infections caused by the enteroviruses (echo and coxsackie) are frequently asymptomatic or produce an undifferentiated febrile illness. Enteroviruses may also be associated with distinctive clinical syndromes such as aseptic meningitis and pleuritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=see_link\">",
"     \"Epidemiology and clinical manifestations of adenovirus infection\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=see_link\">",
"     \"Clinical manifestations and diagnosis of enterovirus and parechovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is not possible to determine the likely viral pathogen on the basis of the observed clinical illness; all of the above viral pathogens may cause similar symptoms. Parainfluenza and RSV are more likely to cause cold symptoms in young children [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of the respiratory viruses that cause colds are capable of reinfection after reexposure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"     1",
"    </a>",
"    ]. However, subsequent infections with the same or similar agents are generally milder and of shorter duration [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/7\">",
"     7",
"    </a>",
"    ]. The molecular and genetic basis for incomplete cross-protection following infection with one strain is not fully understood. However, data from rhinoviruses suggest that his may be due in part to a remarkable degree of structural and molecular variability, both within serotypes and between the divergent field strains that frequently arise from a given reference virus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Seasonal patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seasonal patterns of infection can be observed for some of the viruses that cause the common cold. Rhinoviruses and the various parainfluenza types typically cause outbreaks of infection in fall and late spring, while RSV and coronaviruses typically produce epidemics in winter and spring [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1,5,9\">",
"     1,5,9",
"    </a>",
"    ]. Enteroviruses most often cause illness in the summer, but can be detected throughout the year. Adenoviruses are usually not seasonal but outbreaks may occur in military facilities, daycare centers, and hospital wards.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;Common cold viruses can be spread by three mechanisms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hand contact (via direct contact with an infected person or via indirect contact with a contaminated environmental surface)",
"     </li>",
"     <li>",
"      Small particle droplets (droplet transmission) that become airborne from sneezing or coughing",
"     </li>",
"     <li>",
"      Large particle droplets that typically require close contact with an infected person",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The importance of hand-to-hand virus transmission has been repeatedly demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/10\">",
"     10",
"    </a>",
"    ]. In one classic study, volunteers were exposed to rhinovirus; 0 of 8 subjects became ill in the group where fingers were treated with 2 percent aqueous iodine, compared to infection in 6 of the 10 subjects in the control group [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, alcohol-based gels that quickly evaporate may be less effective. In one observational study of families with children attending daycare, multivariate analysis found that use of an alcohol-based hand gel was associated with a decreased risk for household respiratory infection (RR 0.6, 95% CI 0.4-0.9) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/12\">",
"     12",
"    </a>",
"    ]. However, other studies have not found a consistent effect of alcohol gels or general hand hygiene in the prevention of respiratory illness [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. The use of virucidal impregnated nasal tissues may also reduce the transmission of cold viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cold-inducing viruses may remain viable on human skin for up to two hours. The risk of person-to-person transfer is dependent upon the amount of time people spend together, the proximity of their contact with one another, and the amount of virus shed by the infected patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Droplet transmission is the most common means of transmission for both influenza and respiratory syncytial viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/5,17\">",
"     5,17",
"    </a>",
"    ]. Although spread through aerosolized respiratory secretions has also been suggested to occur, it is generally felt that this is of less clinical significance [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Infection may lead to nosocomial spread. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link&amp;anchor=H11#H11\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\", section on 'Transmission'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Viral spread from contaminated fomites is another mechanism of transmission. Rhinoviruses may survive on environmental surfaces for several hours, thus allowing spread from contact with contaminated surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Interestingly, porous materials such as tissues and cotton handkerchiefs do not appear to support virus survival and thus secondary contact with these materials is an inefficient mode of virus transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/22\">",
"     22",
"    </a>",
"    ]. Decontamination of environmental surfaces with virucidal disinfectants such as",
"    <span class=\"nowrap\">",
"     phenol/alcohol",
"    </span>",
"    may help decrease the rate of transmission of cold-inducing viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A randomized double-blind study of the effectiveness of various antibacterial home-cleaning products failed to show a difference, compared to standard products, in the incidence of respiratory symptoms among study patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/23\">",
"     23",
"    </a>",
"    ]. This finding is not a surprise as antibacterial cleaning products would not be expected to have an effect on viral pathogens. Despite these negative findings, and the unresolved question of whether direct hand-to-hand contact or droplet spread is the more important route of transmission, it is reasonable to assume that proper disposal of nasal secretions and adequate handwashing will help to prevent the spread of colds.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Unproven factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possibility that recirculating air in commercial airliners might increase common cold transmission has been proposed. However, a study of 1100 US air passengers (53 percent aboard airplanes with recirculated cabin air and 47 percent aboard aircraft with exclusively fresh air ventilation) found no difference in the postflight rate of persons reporting a cold, runny nose, or a constellation of eight other respiratory symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/24\">",
"     24",
"    </a>",
"    ]. While this single study does not definitively rule out the possibility that recirculating air in airplanes increases transmission risk, it does indirectly support the contention that hand-to-hand transmission is more important than droplet transmission.",
"   </p>",
"   <p>",
"    Saliva is",
"    <strong>",
"     not",
"    </strong>",
"    an efficient means of spread of most cold viruses. Over 90 percent of people with colds have no detectable virus in their saliva [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H904640\">",
"    <span class=\"h2\">",
"     Period of infectivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies that have involved experimental&nbsp;inoculation of subjects with viruses causing the common cold have shown that peak viral shedding with rhinovirus occurs on the second day of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Viral shedding peaks on the third day of the illness after inoculation, which coincides with a peak in symptoms. However, low levels of viral shedding may persist for up to two weeks. Studies have also shown that nasal washings taken five days after onset of a cold illness can produce symptoms of infection when experimentally inoculated into volunteers [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19380906\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for the common cold include exposure to children in daycare settings; at-home parents have greater risk of cold than those who work outside the home [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/4\">",
"     4",
"    </a>",
"    ]. Psychological stress increases the risk of colds [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/27\">",
"     27",
"    </a>",
"    ], and moderate physical exercise decreases the risk [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/28\">",
"     28",
"    </a>",
"    ]. Individuals who have less sleep and preexisting sleep disturbances may have an increased susceptibility to cold virus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is no scientific basis for the popular notion that a cold climate increases susceptibility to respiratory illness. As an example, investigators working in a research base in Antarctica noted that the frequency of colds was equivalent in men after six months in the Antarctic and men just arriving from the United States to begin their Antarctica residence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for increased severity of upper respiratory infection include [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Underlying chronic diseases",
"     </li>",
"     <li>",
"      Congenital immunodeficiency disorders",
"     </li>",
"     <li>",
"      Malnutrition",
"     </li>",
"     <li>",
"      Cigarette smoking",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of the common cold are largely due to the immune response to infection, rather than to direct viral damage to the respiratory tract. Symptoms vary from patient to patient; rhinitis and nasal congestion are most common. Other common symptoms include sore throat, cough and malaise. Fever is uncommon in adults with a cold, but may be present in children; conjunctivitis occurs variably in both age groups. The intensity and type of symptoms of the common cold may also be related to host factors including age, underlying illnesses, and prior immunological experience, as well as to the type of infecting virus [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nasal obstruction, rhinorrhea, and sneezing are usually present early in the course of most colds. A sore or \"scratchy\" throat is frequently the most bothersome symptom on the first day of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/2\">",
"     2",
"    </a>",
"    ]. The symptom of a sore throat is usually short lived. Typically, nasal symptoms predominate by the second and third day of illness. Cough often becomes troublesome on the fourth or fifth day of illness, by which time the nasal symptoms are less severe [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nasal discharge may be purulent in the absence of a secondary bacterial infection. Purulent nasal discharge occurs both in patients with the common cold",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    secondary viral or bacterial rhinosinusitis, and purulence alone cannot distinguish between a cold or sinus infection. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Acute rhinosinusitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Findings on physical examination are typically minimal or few, despite the subjective discomfort of the patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11414490\">",
"    <span class=\"h2\">",
"     Incubation period and symptom duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incubation period (from the time of contact with infectious material until the onset of symptoms) for most common cold viruses is 24 to 72 hours, although in an experimental setting symptom onset can occur as early as 10 to 12 hours after exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colds usually persist for 3 to 10 days in the normal host [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/1,5\">",
"     1,5",
"    </a>",
"    ], although clinical illness may last as long as two weeks in up to 25 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/2\">",
"     2",
"    </a>",
"    ]. Although patients with purulent nasal discharge may be concerned that they have developed a bacterial sinus infection requiring antibiotic treatment, acute bacterial rhinosinusitis is typically diagnosed (in the absence of high fever or worsening of symptoms after initial improvement) only after symptoms have persisted for 10 or more days. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link&amp;anchor=H98446144#H98446144\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\", section on 'Distinguishing bacterial from viral infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11414528\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of the common cold is clinical, based on reported symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the observed signs. Physical examination may reveal conjunctival injection, nasal mucosal swelling, nasal congestion, and pharyngeal erythema. Adenopathy is not prominent and, in the absence of secondary bronchospasm, the lung examination is typically clear.",
"   </p>",
"   <p>",
"    Radiologic studies are not routinely indicated. Chest x-ray to evaluate for lower respiratory tract infection is indicated if the physical examination suggests signs of consolidation or other parenchymal disease. Sinus x-rays or CT scan are not indicated; some form of mucosal abnormality on CT scan may be observed in as many as 42 percent of asymptomatic individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. In one study of 31 patients with self-diagnosed \"colds\" confirmed by viral culture, mucosal thickening or air-fluid levels of the maxillary sinuses were found on CT scan within two to three days of symptom onset in 87 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Viral cultures from nasal swabs or washings are not indicated, except for epidemiologic research purposes. Nasal swab for a rapid influenza test is appropriate during flu season for patients whose symptoms include significant fever (T&ge;101&deg;F or 38&deg;C).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the common cold is usually diagnosed clinically and readily identified by symptoms, several other conditions may mimic the common cold:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Allergic or seasonal rhinitis",
"     </li>",
"     <li>",
"      Bacterial pharyngitis or tonsillitis",
"     </li>",
"     <li>",
"      Acute bacterial rhinosinusitis",
"     </li>",
"     <li>",
"      Influenza",
"     </li>",
"     <li>",
"      Pertussis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The common cold can be differentiated from simple rhinitis by the presence of sore throat and cough, and from bacterial tonsillitis by the presence of prominent rhinorrhea and nasal stuffiness. Patients with acute rhinosinusitis typically experience facial pain in conjunction with purulent nasal discharge, while patients with influenza typically have a high fever, headache, and myalgias. Finally, although pertussis infection may begin with symptoms similar to the common cold, pertussis is associated with prolonged coughing, typically paroxysmal and associated with vomiting and sometimes, apnea. Pertussis may present atypically, particularly in previously immunized adults, and the persistence of severe coughing for more than two weeks is suggestive of pertussis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=see_link\">",
"     \"Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/38/5738?source=see_link\">",
"     \"Evaluation of acute pharyngitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=see_link\">",
"     \"Clinical manifestations of seasonal influenza in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"    </a>",
"    .)&nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Acute rhinosinusitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute bacterial rhinosinusitis is a rare complication in adults with colds. Viral sinusitis occurs more frequently than secondary bacterial sinusitis. Radiographic changes suggestive of sinusitis were noted on day 7 in 39 percent of 197 adults with cold symptoms who had sinus x-rays on days 1, 7, and 21 [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/35\">",
"     35",
"    </a>",
"    ]. Viruses were identified in 82 percent of the patients with radiographic evidence of sinusitis in this study. All patients recovered clinically within 21 days",
"    <strong>",
"     without antibiotic therapy",
"    </strong>",
"    . Purulent nasal discharge was commonly present during the first week of illness in patients who had radiographic evidence of sinusitis by day seven; however, there were no other distinguishing symptoms between groups with and without sinusitis in this study cohort. In particular, no patients developed maxillofacial or dental pain, symptoms more suggestive of bacterial sinusitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=see_link\">",
"     \"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Lower respiratory tract disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract disease among children, older adults, and immunocompromised patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. RSV infections in older adults are often due to reinfections. Such infections can lead to an exacerbation of congestive heart failure and other chronic conditions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=see_link\">",
"     \"Respiratory syncytial virus infection: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29289?source=see_link\">",
"     \"Acute bronchitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Viral upper respiratory infections have been linked to up to 40 percent of acute asthma attacks in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. It is uncertain whether increased airway hyperreactivity is the result of local inflammation caused by viral infection of lower airway epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/41\">",
"     41",
"    </a>",
"    ], or if infection is limited to the upper airway with inflammatory mediators acting distantly in the lower airways. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link\">",
"     \"Risk factors for asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rhinovirus has emerged as the most frequent common cold virus associated with asthma exacerbations. It is thought that the epithelial airway antiviral response to rhinovirus may be defective in patients with asthma [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/42\">",
"     42",
"    </a>",
"    ]. However, in a study that compared experimental inoculation of rhinovirus in 20 subjects with mild persistent allergic asthma and 18 healthy adults, there was no difference in peak cold symptom score, peak nasal viral titers, peak airway flow, or measures of cellular and cytokine responses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rhinovirus-induced changes in airway reactivity may persist for up to four weeks following infection [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/44\">",
"     44",
"    </a>",
"    ]. These changes in airway reactivity may explain why some individuals develop a persistent cough following upper respiratory tract infections. However, other causes of cough, such as pertussis, should be considered when individuals develop persistent cough following a presumed viral respiratory tract infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Acute otitis media",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral upper respiratory infection (URI) often causes Eustachian tube dysfunction; impaired clearance and pressure regulation of the middle ear may then lead to acute otitis media [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/45\">",
"     45",
"    </a>",
"    ]. Although otitis media following URI is more common in children than adults, when normal adults were experimentally exposed to rhinovirus or influenza A virus, 50 to 80 percent developed Eustachian tube dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/46\">",
"     46",
"    </a>",
"    ]. In addition to inducing Eustachian tube disturbance, respiratory viruses can be isolated directly from middle-ear fluid, suggesting that viruses may also actively invade the middle ear and cause acute otitis media [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24440/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=see_link&amp;anchor=H19#H19\">",
"     \"Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications\", section on 'Viruses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/53/17234?source=see_link\">",
"       \"Patient information: Sinusitis in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/13/37073?source=see_link\">",
"       \"Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=see_link\">",
"       \"Patient information: The common cold in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The common cold is the most frequent acute illness in the industrialized world, with two to three episodes of illness occurring in adults yearly. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Over 200 subtypes of viruses have been associated with the common cold. Rhinoviruses cause 30 to 50 percent of colds. It is not possible to identify the likely viral pathogen on the basis of clinical symptoms. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Virology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of upper respiratory infections (URIs) are transmitted by hand contact; cold-inducing viruses may remain viable on human skin for at least two hours. Recirculated air on commercial airplanes and cold temperature exposure do not seem to increase risk. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Transmission'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19380906\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms of the common cold are largely due to the immune response to infection. Purulent nasal discharge occurs both in patients with the common cold",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      secondary viral or bacterial rhinosinusitis, and purulence alone cannot distinguish between a cold or sinus infection. Colds usually persist for 3 to 10 days in the normal host, although clinical illness may last as long as two weeks in up to 25 percent of patients. Acute bacterial rhinosinusitis is typically diagnosed (in the absence of high fever or worsening of symptoms after initial improvement) only after symptoms have persisted for 10 or more days. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of the common cold is clinical, based on reported symptoms",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the observed signs. Sinus x-rays or CT scan are not indicated; some form of mucosal abnormality on CT scan may be observed in as many as 42 percent of asymptomatic individuals. Nasal swab for a rapid influenza test is appropriate during flu season for patients whose symptoms include significant fever (T&ge;101&deg;F or 38&deg;C). (See",
"      <a class=\"local\" href=\"#H11414528\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of the common cold may include acute rhinosinusitis, lower respiratory tract disease, asthma exacerbation, or acute otitis media. Viral sinusitis occurs frequently in the course of an upper respiratory infection and resolves without antibiotic treatment. Viral URIs have been linked to 40 percent of acute asthma attacks in adults. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/1\">",
"      Kirkpatrick GL. The common cold. Prim Care 1996; 23:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/2\">",
"      Turner RB. Epidemiology, pathogenesis, and treatment of the common cold. Ann Allergy Asthma Immunol 1997; 78:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/3\">",
"      Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003; 163:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/4\">",
"      Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev 1994; 16:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/5\">",
"      Heikkinen T, J&auml;rvinen A. The common cold. Lancet 2003; 361:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/6\">",
"      Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis 2005; 5:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/7\">",
"      JACKSON GG, DOWLING HF. Transmission of the common cold to volunteers under controlled conditions. IV. Specific immunity to the common cold. J Clin Invest 1959; 38:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/8\">",
"      Palmenberg AC, Spiro D, Kuzmickas R, et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009; 324:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/9\">",
"      Sung RY, Murray HG, Chan RC, et al. Seasonal patterns of respiratory syncytial virus infection in Hong Kong: a preliminary report. J Infect Dis 1987; 156:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/10\">",
"      Turner RB, Hendley JO. Virucidal hand treatments for prevention of rhinovirus infection. J Antimicrob Chemother 2005; 56:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/11\">",
"      Gwaltney JM Jr, Moskalski PB, Hendley JO. Interruption of experimental rhinovirus transmission. J Infect Dis 1980; 142:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/12\">",
"      Lee GM, Salomon JA, Friedman JF, et al. Illness transmission in the home: a possible role for alcohol-based hand gels. Pediatrics 2005; 115:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/13\">",
"      Sandora TJ, Taveras EM, Shih MC, et al. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics 2005; 116:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/14\">",
"      Roberts L, Smith W, Jorm L, et al. Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics 2000; 105:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/15\">",
"      Falsey AR, Criddle MM, Kolassa JE, et al. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers. Infect Control Hosp Epidemiol 1999; 20:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/16\">",
"      Dick EC, Hossain SU, Mink KA, et al. Interruption of transmission of rhinovirus colds among human volunteers using virucidal paper handkerchiefs. J Infect Dis 1986; 153:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/17\">",
"      Hall CB, Douglas RG Jr. Modes of transmission of respiratory syncytial virus. J Pediatr 1981; 99:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/18\">",
"      Lindsley WG, Blachere FM, Davis KA, et al. Distribution of airborne influenza virus and respiratory syncytial virus in an urgent care medical clinic. Clin Infect Dis 2010; 50:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/19\">",
"      Tellier R. Review of aerosol transmission of influenza A virus. Emerg Infect Dis 2006; 12:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/20\">",
"      Gwaltney JM Jr, Hendley JO. Transmission of experimental rhinovirus infection by contaminated surfaces. Am J Epidemiol 1982; 116:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/21\">",
"      Winther B, McCue K, Ashe K, et al. Rhinovirus contamination of surfaces in homes of adults with natural colds: transfer of virus to fingertips during normal daily activities. J Med Virol 2011; 83:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/22\">",
"      Hall CB, Douglas RG Jr, Geiman JM. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 1980; 141:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/23\">",
"      Larson EL, Lin SX, Gomez-Pichardo C, Della-Latta P. Effect of antibacterial home cleaning and handwashing products on infectious disease symptoms: a randomized, double-blind trial. Ann Intern Med 2004; 140:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/24\">",
"      Zitter JN, Mazonson PD, Miller DP, et al. Aircraft cabin air recirculation and symptoms of the common cold. JAMA 2002; 288:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/25\">",
"      Hendley JO, Gwaltney JM Jr. Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection. J Clin Virol 2004; 30:326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/26\">",
"      Douglas RG Jr, Cate TR, Gerone PJ, Couch RB. Quantitative rhinovirus shedding patterns in volunteers. Am Rev Respir Dis 1966; 94:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/27\">",
"      Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/28\">",
"      Nieman DC. Exercise, upper respiratory tract infection, and the immune system. Med Sci Sports Exerc 1994; 26:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/29\">",
"      Cohen S, Doyle WJ, Alper CM, et al. Sleep habits and susceptibility to the common cold. Arch Intern Med 2009; 169:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/30\">",
"      Warshauer DM, Dick EC, Mandel AD, et al. Rhinovirus infections in an isolated antarctic station. Transmission of the viruses and susceptibility of the population. Am J Epidemiol 1989; 129:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/31\">",
"      Tyrrell DA, Cohen S, Schlarb JE. Signs and symptoms in common colds. Epidemiol Infect 1993; 111:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/32\">",
"      Havas TE, Motbey JA, Gullane PJ. Prevalence of incidental abnormalities on computed tomographic scans of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 1988; 114:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/33\">",
"      Bolger WE, Butzin CA, Parsons DS. Paranasal sinus bony anatomic variations and mucosal abnormalities: CT analysis for endoscopic sinus surgery. Laryngoscope 1991; 101:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/34\">",
"      Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med 1994; 330:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/35\">",
"      Puhakka T, M&auml;kel&auml; MJ, Alanen A, et al. Sinusitis in the common cold. J Allergy Clin Immunol 1998; 102:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/36\">",
"      Wendt CH, Hertz MI. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin Respir Infect 1995; 10:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/37\">",
"      Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis 1999; 179:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/38\">",
"      Mlinaric-Galinovic G, Falsey AR, Walsh EE. Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis 1996; 15:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/39\">",
"      Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997; 112:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/40\">",
"      Kistler A, Avila PC, Rouskin S, et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 2007; 196:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/41\">",
"      Gern JE, Galagan DM, Jarjour NN, et al. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/42\">",
"      Kelly JT, Busse WW. Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol 2008; 122:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/43\">",
"      DeMore JP, Weisshaar EH, Vrtis RF, et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol 2009; 124:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/44\">",
"      Folkerts G, Nijkamp FP. Virus-induced airway hyperresponsiveness. Role of inflammatory cells and mediators. Am J Respir Crit Care Med 1995; 151:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/45\">",
"      Rovers MM, Schilder AG, Zielhuis GA, Rosenfeld RM. Otitis media. Lancet 2004; 363:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/46\">",
"      McBride TP, Doyle WJ, Hayden FG, Gwaltney JM Jr. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch Otolaryngol Head Neck Surg 1989; 115:1054.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24440/abstract/47\">",
"      Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med 1999; 340:260.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6865 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-F708DC0240-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24440=[""].join("\n");
var outline_f23_55_24440=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VIROLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Seasonal patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Transmission",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Unproven factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H904640\">",
"      Period of infectivity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19380906\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11414490\">",
"      Incubation period and symptom duration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11414528\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Acute rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Lower respiratory tract disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Acute otitis media",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6865\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6865|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/35/21051\" title=\"table 1\">",
"      Viral cause common cold",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/38/29289?source=related_link\">",
"      Acute bronchitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/60/29642?source=related_link\">",
"      Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/48/39688?source=related_link\">",
"      Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/53/22362?source=related_link\">",
"      Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13911?source=related_link\">",
"      Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/49/34585?source=related_link\">",
"      Clinical manifestations and diagnosis of enterovirus and parechovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18456?source=related_link\">",
"      Clinical manifestations of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/25/5528?source=related_link\">",
"      Diagnosis of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/21/39257?source=related_link\">",
"      Epidemiology and clinical manifestations of adenovirus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/59/19383?source=related_link\">",
"      Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/38/5738?source=related_link\">",
"      Evaluation of acute pharyngitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/38/617?source=related_link\">",
"      Parainfluenza viruses in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/13/37073?source=related_link\">",
"      Patient information: Acute sinusitis (sinus infection) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/53/17234?source=related_link\">",
"      Patient information: Sinusitis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/11/44210?source=related_link\">",
"      Patient information: The common cold in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/56/7050?source=related_link\">",
"      Respiratory syncytial virus infection: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=related_link\">",
"      Risk factors for asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/52/30537?source=related_link\">",
"      The common cold in adults: Treatment and prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/48/22281?source=related_link\">",
"      The common cold in children: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/53/13146?source=related_link\">",
"      The common cold in children: Treatment and prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_55_24441="Prostate cancer in elderly patients";
var content_f23_55_24441=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Prostate cancer in elderly patients",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Jonathan L Wright, MD, MS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Paul H Lange, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24441/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24441/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/55/24441/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H695146355\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prostate cancer in elderly men is particularly important because of the high incidence and prevalence of disease and mortality in this group of patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of prostate cancer is strongly correlated with age and disproportionately affects the elderly. In the United States, 35 percent of cases from 2003 to 2007 were in men aged 65 to 74, and another 25 percent were in men 75 years or older [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/1\">",
"       1",
"      </a>",
"      ]. Prostate cancer incidence rates rapidly rise with increasing age starting around age 50 years, with the highest rates seen in those aged 70 to 80 years (",
"      <a class=\"graphic graphic_figure graphicRef50706 \" href=\"UTD.htm?9/5/9310\">",
"       figure 1",
"      </a>",
"      ). Thus the estimated prevalence for men aged 75 years or greater is over one million men [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Prostate cancer is the third most common cause of cancer death among men aged 80 years and older [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/2\">",
"       2",
"      </a>",
"      ]. Although the case-fatality rate of prostate cancer is quite low, deaths occur disproportionately in the elderly, owing to the long natural history of the disease. Thus, 41 percent of men who die of prostate cancer are between age 75 to 84 years and 30 percent are 85 years or older.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Recommendations for the management of prostate cancer in the elderly are particularly difficult because of issues specific to this group and because clinical trials in prostate cancer often excluded elderly patients.",
"   </p>",
"   <p>",
"    The initial treatment for elderly men with prostate cancer and the management of advanced disease will be reviewed here. The approach to these issues in younger patients is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16969?source=see_link\">",
"     \"Initial approach to low-risk clinically localized prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=see_link\">",
"     \"Initial management of regionally localized intermediate and high risk prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link\">",
"     \"Overview of the treatment of disseminated prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13013302\">",
"    <span class=\"h1\">",
"     PATIENT CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Geriatric patients often have less functional independence, a greater number of medical comorbidities and associated medications, a decline in cognitive and nutritional status,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a lack of social support [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=see_link&amp;anchor=H3#H3\">",
"     \"Comprehensive geriatric assessment for patients with cancer\", section on 'Domains of a CGA'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These issues have been integrated into the management of older men with prostate cancer by the International Society of Geriatric Oncology (SIOG) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. They recommended that treatment decisions should be based upon several standardized assessments, which can be easily and quickly administered in the clinical setting. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An evaluation of an individual&rsquo;s comorbidities (ie, Cumulative Illness Score Rating-Geriatrics (CISR-G)) &ndash; CISR-G rates comorbid conditions on a 0 to 4 scale:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Grade 0: no problem",
"     </li>",
"     <li>",
"      Grade 1: current mild problem or past significant problem",
"     </li>",
"     <li>",
"      Grade 2: moderate disability or morbidity, requires first-line therapy",
"     </li>",
"     <li>",
"      Grade 3:",
"      <span class=\"nowrap\">",
"       severe/constant",
"      </span>",
"      significant",
"      <span class=\"nowrap\">",
"       disability/uncontrollable",
"      </span>",
"      chronic problem",
"     </li>",
"     <li>",
"      Grade 4: extremely",
"      <span class=\"nowrap\">",
"       severe/immediate",
"      </span>",
"      treatment",
"      <span class=\"nowrap\">",
"       required/end-organ",
"      </span>",
"      <span class=\"nowrap\">",
"       failure/severe",
"      </span>",
"      impairment in function",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Dependence (eg, activities of daily living (ADL) that address home independence)",
"     </li>",
"     <li>",
"      Instrumental Activities of Daily Living (IADL), which assess independence in the community setting (",
"      <a class=\"graphic graphic_table graphicRef63647 \" href=\"UTD.htm?43/3/44093\">",
"       table 1",
"      </a>",
"      ). The IADL scale can be modified further as the SIOG recognized that all eight categories of the IADL scale may not be appropriate for a male population and thus allow for only four items to be used in the screening [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/4\">",
"       4",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Financial management",
"     </li>",
"     <li>",
"      Medication management",
"     </li>",
"     <li>",
"      Use of transportation",
"     </li>",
"     <li>",
"      Use of the telephone",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nutritional status &ndash; An individual&rsquo;s nutritional status can be estimated by determining weight loss over the preceding three months:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Good nutritional status, &lt;5 percent of weight loss",
"     </li>",
"     <li>",
"      Risk of malnutrition, weight loss 5 to 10 percent",
"     </li>",
"     <li>",
"      Severe malnutrition, weight loss &gt;10 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With this information, a patient can be categorized into one of four groups:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Healthy &ndash; No serious comorbidities (CISR-G Grade 0, 1, 2), functionally independent in IADLS and ADLs, no malnutrition",
"     </li>",
"     <li>",
"      Vulnerable with a reversible problem &ndash; One uncontrolled comorbidity (CISR-G Grade 3), dependent in one or more IADLs but functionally independent in ADLs, at risk for malnutrition",
"     </li>",
"     <li>",
"      Frail with a non-reversible problem &ndash; &ge;2 Grade 3 CISR-G or one Grade 4 CISR-G comorbidity, dependent in one or more ADLs, malnutrition present",
"     </li>",
"     <li>",
"      Terminal &ndash; Bedridden, major comorbidities, cognitive impairment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Using this classification system, management of the elderly patient with prostate cancer should be based upon an individual&rsquo;s health state rather than chronologic age. In complicated cases, a formal evaluation by a geriatrician may be needed [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/3\">",
"     3",
"    </a>",
"    ]. A comprehensive geriatric assessment is also recommended by the National Comprehensive Cancer Network Clinical Practice Guidelines for senior adult oncology [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=see_link&amp;anchor=H15#H15\">",
"     \"Comprehensive geriatric assessment for patients with cancer\", section on 'Use of CGA results'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A related issue, both for issues of screening and management of patients in whom prostate cancer has been diagnosed, is that clinicians have only limited ability to predict life expectancy in men with localized prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. Because life tables do not consider factors other than an individual&rsquo;s chronologic age, they do not accurately predict survival in men with multiple comorbidities. In a study of men with prostate cancer, life expectancy tables overestimated survival by 32 percent in those men with a Charlson Comorbidity Index of &ge;3 (",
"    <a class=\"graphic graphic_table graphicRef72047 \" href=\"UTD.htm?25/40/26252\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/9\">",
"     9",
"    </a>",
"    ]. Nomograms are available to predict 10-year life expectancy in men with localized prostate cancer that may be more accurate than life tables because they take into account comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"./survival-estimates-in-advanced-terminal-cancer?source=see_link\">",
"     \"Survival estimates in advanced terminal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146363\">",
"    <span class=\"h1\">",
"     PROSTATE CANCER SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of prostate cancer screening is controversial, both in elderly patients and in younger men. The issues and screening guidelines are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/8/42122?source=see_link\">",
"     \"Screening for prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146370\">",
"    <span class=\"h1\">",
"     TREATMENT OF LOCALIZED DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Potentially curative treatment options for the elderly patient with localized prostate cancer include radiation therapy (both external beam and brachytherapy) and radical prostatectomy. Other standard options include observation, either as active surveillance (ie, careful monitoring with PSA, rectal exams, and periodic biopsies with potentially curative treatment on progression) or watch and wait (observation until the patient becomes symptomatically progressive before treatment is instituted). Hormone therapy is also widely used, although its role is less certain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16969?source=see_link\">",
"     \"Initial approach to low-risk clinically localized prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=see_link\">",
"     \"Initial management of regionally localized intermediate and high risk prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several publications have reported on the treatment options actually used for elderly men [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Data from CaPSURE indicate that for men over the age of 75 years, the most common treatment was primary androgen deprivation therapy (42 percent), followed by radiation therapy (34 percent) and watchful waiting (19 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/14\">",
"     14",
"    </a>",
"    ]. Cryotherapy (3.1 percent) and RP (2.6 percent) were the least common treatments. In the CaPSURE database, men &ge;75 years were more likely to be managed with active surveillance or watchful waiting even after adjusting for age, comorbidities, and disease risk compared with men &lt;75 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258749388\">",
"    <span class=\"h2\">",
"     Impact of disease on survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data on the natural history of untreated prostate cancer indicate that although there are more deaths due to competing risks in men over the age of 70 years, especially in those with lower grade disease, a large proportion of men over the age of 70 at diagnosis will eventually die of prostate cancer. In one series, for example, more than 50 percent of men aged 70 to 74 years with untreated localized high grade disease died of prostate cancer within 20 years of diagnosis, with most deaths occurring within 10 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/15\">",
"     15",
"    </a>",
"    ]. In another series where PSA and Gleason data were available, the 10-year prostate cancer-specific mortality rates for men with Gleason 8 to 10 cancer who were over the age of 70 were approximately 40, 50 and 70 percent within PSA strata of &lt;10",
"    <span class=\"nowrap\">",
"     ng/dL,",
"    </span>",
"    10 to 24.9",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    and 25 to 100",
"    <span class=\"nowrap\">",
"     ng/dL,",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/16\">",
"     16",
"    </a>",
"    ]. These data support aggressive treatment in men with high-risk disease, although less than one-third of new diagnoses are in this high risk category [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An analysis of the Surveillance, Epidemiology, and End Results (SEER) Medicare database analyzed the risk of overall mortality after adjusting for comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/18\">",
"     18",
"    </a>",
"    ]. The median age of the cohort was 73 years of age. Men with well or moderately differentiated prostate cancer and localized disease (T1-T2) had excellent overall survival, which was not significantly different from those without prostate cancer (",
"    <a class=\"graphic graphic_table graphicRef75565 \" href=\"UTD.htm?40/19/41277\">",
"     table 3",
"    </a>",
"    ). In this group, cardiovascular disease was the leading cause of death. However, the risk of overall mortality was greater in those with Gleason 8&ndash;10 prostate cancer compared to those without prostate cancer, even for those with T1 disease. A separate decision analysis study concluded that a 75 year old man with no comorbidities and Gleason 8&ndash;10 prostate cancer would experience a one year increase in quality adjusted life year with treatment with curative intent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/19\">",
"     19",
"    </a>",
"    ]. However, the analysis also showed that a 75 year-old man with moderately differentiated disease and a symptomatic but controlled comorbidity would not see any improvement with active treatment over observation. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258749381\">",
"    <span class=\"h2\">",
"     Organizational guidelines",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several groups have developed formal prostate cancer guidelines for elderly men.",
"   </p>",
"   <p>",
"    One of the first was the state of Iowa, with the third highest proportion of men over the age of 65 in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/20\">",
"     20",
"    </a>",
"    ]. A panel of urologists, geriatricians, medical and radiation oncologists, primary care physicians, lawyers, and patient advocates developed guidelines based upon expert opinion. They recommend that treatment for elderly men be driven by risk stratification. Men with low or intermediate risk disease should be managed with observation (ie, active",
"    <span class=\"nowrap\">",
"     surveillance/watchful",
"    </span>",
"    waiting) with radiation therapy should symptoms develop. This group highlighted the importance of a functional and cognitive assessment in the decision making process. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9704?source=see_link\">",
"     \"Prostate cancer: Risk stratification, other prognostic factors, and predictive tools\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most extensive recommendations are those of the International Society of Geriatric Oncology (SIOG), which provide a decision tree for managing men with localized prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Healthy &ndash; Same treatment approach as for younger patients",
"     </li>",
"     <li>",
"      Vulnerable with a reversible problem &ndash; Same treatment as for younger patients, excluding radical prostatectomy, with appropriate management of underlying problems",
"     </li>",
"     <li>",
"      Frail with a non-reversible problem &ndash; Symptomatic management without definitive treatment (eg, androgen deprivation therapy)",
"     </li>",
"     <li>",
"      Terminal &ndash; Palliative treatment only",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The NCCN Guidelines for senior adult oncology also support the use of a comprehensive geriatric assessment, and conclude that a person who is functionally independent and without serious comorbidity should be a good candidate for most forms of cancer treatments irrespective of age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146377\">",
"    <span class=\"h2\">",
"     Radical prostatectomy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13014038\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Assessing the effectiveness of radical prostatectomy in elderly men with localized prostate cancer is difficult. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24313?source=see_link\">",
"     \"Radical prostatectomy for localized prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although a randomized trial found that radical prostatectomy in men with localized prostate cancer improved disease-specific survival compared with watchful waiting, the study excluded men over age 75 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/21\">",
"     21",
"    </a>",
"    ]. Furthermore, the survival advantage was seen only in those under age 65 years in subset analyses.",
"   </p>",
"   <p>",
"    Observational data do support a role for radical prostatectomy in selected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/22-28\">",
"     22-28",
"    </a>",
"    ]. As an example, in a study of 4500 men undergoing surgery, 17 percent of whom were older than 70 years, higher grade and higher stage disease was seen in those aged 70 or greater compared to younger cohorts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/23\">",
"     23",
"    </a>",
"    ]. Although unadjusted disease-specific survival was worse in those aged &ge;70 years, age was not a significant predictor of survival on multivariate analysis that incorporated stage and grade. This is similar to other series that found worse pathological characteristics at radical prostatectomy from older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/24,25\">",
"     24,25",
"    </a>",
"    ], but similar or better disease-specific survival compared with younger cohorts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. In another series of 386 men over the age of 70 years, the 15-year prostate cancer-specific and overall survival rates were 90 and 69 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/27\">",
"     27",
"    </a>",
"    ]. This is better than a population-based cohort of men over the age of 70 from which the 10-year overall survival for men undergoing radical prostatectomy was 59 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A predictive model that included an individual&rsquo;s comorbidities was developed to improve the accuracy of predicting overall mortality in men with prostate cancer undergoing surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/29\">",
"     29",
"    </a>",
"    ]. This model incorporates Gleason grade, serum PSA, and Charlson comorbidity index (",
"    <a class=\"graphic graphic_table graphicRef72047 \" href=\"UTD.htm?25/40/26252\">",
"     table 2",
"    </a>",
"    ) to illustrate the impact of the degree of comorbidity on overall survival in men over the age of 70 years who undergo radical prostatectomy (",
"    <a class=\"graphic graphic_table graphicRef74222 \" href=\"UTD.htm?17/36/17996\">",
"     table 4",
"    </a>",
"    ). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146384\">",
"    <span class=\"h3\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the biggest concerns of radical prostatectomy in elderly men is the higher rate of complications compared with younger persons, particularly related to urinary and sexual function. As an example, in one large series, the rate of complications increased progressively with age (4, 7, 9 and 14 percent for ages 40 to 49, 50 to 59, 60 to 69 and &ge;70 years, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24313?source=see_link&amp;anchor=H24077788#H24077788\">",
"     \"Radical prostatectomy for localized prostate cancer\", section on 'Complications and quality of life'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several studies have reported higher rates of urinary and sexual dysfunction in elderly men. In a population-based study, frequent urinary leakage was significantly less common at two years postoperatively in men less than 74 years of age compared with those 75 to 79 years (5 to 10 percent versus 27 percent, p = 0.03) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/31\">",
"     31",
"    </a>",
"    ]. Similarly, potency rates were lower in men 75 to 79 years compared with those under age 60 years (19 versus 39 percent). This population-based study also collected data on men treated conservatively. Compared with those treated surgically or with radiation therapy, those treated conservatively had less urinary and bowel issues at two years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Older men may require secondary interventions more frequently following radical prostatectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/33\">",
"     33",
"    </a>",
"    ]. Compared with young men (age &lt;50 years), a higher proportion of men over the age of 70 years required treatment for anastomotic strictures (10.8 versus 5.8 percent) or placement of artificial urinary sphincters (2.5 versus 0.5 percent). Data from CaPSURE show that men over the age of 65 are less likely to return to potency, continence, and physical health one year after radical prostatectomy [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/34\">",
"     34",
"    </a>",
"    ]. Although single institution series report higher overall continence and potency rates compared with multi-institutional databases, such reports still suggest lower rates in elderly compared with younger men [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/30,35,36\">",
"     30,35,36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146391\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13014072\">",
"    <span class=\"h3\">",
"     Disease control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation therapy (RT) is used more commonly than radical prostatectomy in elderly men with localized prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/12,14,37\">",
"     12,14,37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23290?source=see_link\">",
"     \"External beam radiation therapy for localized prostate cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32824?source=see_link\">",
"     \"Brachytherapy for localized prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one study of 381 men age 75 years or older, external beam RT was associated with worse prostate cancer-specific survival in men with high-risk disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/38\">",
"     38",
"    </a>",
"    ]. Another study of 2474 men with localized disease receiving either brachytherapy alone or brachytherapy with neoadjuvant ADT found increased overall mortality in elderly (&ge;73 years, n = 1268) men receiving combined treatment (adjusted HR 1.24, 95% CI 1.01 &ndash; 1.53) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/39\">",
"     39",
"    </a>",
"    ]. This increased overall mortality was not seen in men younger than 73 years of age (p = 0.34). In this study, only 12 percent of men had high risk disease, and prostate cancer-specific survival was not reported. Other studies have not found advanced age to be associated with biochemical recurrence after RT [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The effect of comorbidities rather than age on survival has been studied following RT for prostate cancer. A randomized study of external beam RT with or without six-months ADT found that the survival advantage for intermediate and high-risk patients was only seen in those with minimal or no medical comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/42\">",
"     42",
"    </a>",
"    ]. Secondary analyses of men with biochemical failure in this cohort have demonstrated that those with moderate to severe comorbidities are at significant risk of non-prostate cancer related death, highlighting the potential need for stratifying men prior to initiating salvage therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. In a separate study of 1978 men with intermediate-risk disease aged 66 to 75 years (median 71 years) undergoing RT, the role of cardiovascular disease in survival outcomes was explored [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/45\">",
"     45",
"    </a>",
"    ]. Men with cardiovascular disease had a reduction in the risk of prostate cancer-specific mortality (HR 0.20, 95% CI 0.04 &ndash; 0.99), perhaps due to competing risks for mortality. &nbsp;",
"   </p>",
"   <p>",
"    In contrast to these studies of men with comorbidities, analyses of healthy men have suggested that aggressive RT is beneficial to elderly men with high-risk disease. In a retrospective study of 764 healthy elderly (age &ge;65 years) men with high-risk disease, brachytherapy alone was compared to brachytherapy combined with external beam RT and four months of androgen deprivation therapy (ADT) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/46\">",
"     46",
"    </a>",
"    ]. Healthy was defined as no history of diabetes, congestive heart failure and coronary artery disease, or corrected (surgically or stented) coronary artery disease. At a median follow-up of 4.9 years, those receiving combined treatment had a 70 percent reduction in prostate cancer-specific mortality compared to those receiving brachytherapy only (HR 0.29, 95% CI 0.12 &ndash; 0.68). In another study of 5077 men treated with RT, neoadjuvant ADT was not associated with an increased risk of overall mortality in men with few or no comorbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/47\">",
"     47",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13014089\">",
"    <span class=\"h2\">",
"     Side effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies are conflicting as to whether or not age is an independent predict of genitourinary and gastrointestinal side effects after RT. Some articles have found similar side effect profiles for older men undergoing RT compared to their younger counterparts [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/48-50\">",
"     48-50",
"    </a>",
"    ], whereas others have found advanced age to be predictive of increased local side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. Studies have also suggested that men over the age of 70 develop toxicities more quickly [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/51\">",
"     51",
"    </a>",
"    ]. Studies on brachytherapy have found that comorbid conditions are an important predictor of complications along with age [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. From an analysis of SEER-Medicare, a higher Charlson Comorbidity Index (",
"    <a class=\"graphic graphic_table graphicRef72047 \" href=\"UTD.htm?25/40/26252\">",
"     table 2",
"    </a>",
"    ) and advanced age were both associated with increased urinary and bowel complications [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/54\">",
"     54",
"    </a>",
"    ]. Another study of 528 men undergoing RT found functional outcomes to be affected by both age and comorbidity, especially diabetes [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/55\">",
"     55",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23290?source=see_link&amp;anchor=H19#H19\">",
"     \"External beam radiation therapy for localized prostate cancer\", section on 'Complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146405\">",
"    <span class=\"h2\">",
"     Androgen deprivation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) has been used commonly in elderly men as a primary treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/12,14,37\">",
"     12,14,37",
"    </a>",
"    ]. However, increasing data have raised concern over this practice, and the use of ADT has declined in recent years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/37\">",
"     37",
"    </a>",
"    ]. These concerns are based upon multiple studies suggesting an increased mortality and shorter survival in patients given ADT; these studies are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16969?source=see_link&amp;anchor=H834295#H834295\">",
"     \"Initial approach to low-risk clinically localized prostate cancer\", section on 'Androgen deprivation therapy alone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2007 AUA guidelines panel recommended that primary ADT not be included among the standard treatment options for men with localized prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/56\">",
"     56",
"    </a>",
"    ]. NCCN guidelines also do not endorse primary ADT as a treatment option for men with clinically localized disease [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H695146339\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF ADVANCED PROSTATE CANCER",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258747715\">",
"    <span class=\"h2\">",
"     Hormone-sensitive prostate cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial management of elderly men with advanced",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    symptomatic prostate cancer generally is hormonal therapy, beginning with androgen deprivation therapy (ADT). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The side effects of ADT are of particular concern in elderly patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ADT is associated with an increased risk of fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/58,59\">",
"       58,59",
"      </a>",
"      ], and these men have a higher likelihood of being osteopenic [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/60\">",
"       60",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link&amp;anchor=H7#H7\">",
"       \"Side effects of androgen deprivation therapy\", section on 'Osteoporosis and bone fractures'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endocrine changes occur with ADT, including a higher risk of developing the metabolic syndrome and diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/61-65\">",
"       61-65",
"      </a>",
"      ]. The prevalence of the metabolic syndrome increases with age [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/66\">",
"       66",
"      </a>",
"      ], indicating that older men started on ADT may either have or be at risk of developing or worsening aspects of the metabolic syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link&amp;anchor=H20#H20\">",
"       \"Side effects of androgen deprivation therapy\", section on 'Changes in body composition and metabolism'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link&amp;anchor=H22#H22\">",
"       \"Side effects of androgen deprivation therapy\", section on 'Cardiovascular disease and diabetes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Men treated with ADT may be at higher risk of developing coronary artery disease and all-cause mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/67,68\">",
"       67,68",
"      </a>",
"      ]. The relationship between coronary artery disease and treatment with ADT is discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link&amp;anchor=H22#H22\">",
"       \"Side effects of androgen deprivation therapy\", section on 'Cardiovascular disease and diabetes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Men receiving ADT are more likely to have the diagnosis of depression and constitutional symptoms (eg, fatigue, anorexia, debility) than men not receiving ADT [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/69\">",
"       69",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link&amp;anchor=H31#H31\">",
"       \"Side effects of androgen deprivation therapy\", section on 'Emotional and cognitive changes'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link&amp;anchor=H25#H25\">",
"       \"Side effects of androgen deprivation therapy\", section on 'Fatigue'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In conclusion, although ADT is an important aspect in the management of prostate cancer, the potential complications of such therapy and the interaction with existing comorbidities need to be considered on an individualized basis. In addition, its role in combination with radiation therapy needs to be carefully considered due to the higher rate of adverse events in such men.",
"   </p>",
"   <p>",
"    Consideration may be given for intermittent androgen deprivation (IAD) in elderly men in an attempt to decrease the side effect profile. However, the long-term impact of IAD on survival, optimal timing, triggers for initiation of additional treatment, and the populations who are candidates for IAD have not been defined. The expert panel from the American Society of Clinical Oncology (ASCO) has concluded that data are insufficient to support the use of IAD outside of a clinical trial [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258747729\">",
"    <span class=\"h2\">",
"     Castrate-resistant prostate cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;As for men with localized disease, the International Society of Geriatric Oncology (SIOG) decision tree for castrate-resistant prostate cancer relies upon the health status of an individual patient in recommending treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Healthy men should receive standard chemotherapy. Vulnerable men should receive standard chemotherapy after",
"    <span class=\"nowrap\">",
"     correction/treatment",
"    </span>",
"    of the specific reversible impairment. The standard chemotherapy regimen castrate-resistant prostate cancer is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    every three weeks) with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    . Subset analyses of the trials establishing the role of this approach have shown that older men, including those &ge;75 years, responded as well as younger patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link&amp;anchor=H8#H8\">",
"     \"Chemotherapy in castrate-resistant prostate cancer\", section on 'Chemotherapy-naive patients: docetaxel'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because of concerns about myelosuppression and other adverse effects of chemotherapy in elderly patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/73,74\">",
"     73,74",
"    </a>",
"    ], studies have explored lower dosing of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    (30",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    weekly) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/75-77\">",
"     75-77",
"    </a>",
"    ]. Results have suggested this dosing may be effective against cancer progression with a lower rate of myelosuppression although not improving overall survival. However, a review of patients treated with either three weekly (n = 96) or weekly (n = 80) docetaxel found that there was a greater percentage of drop-outs with the weekly regimen compared with the three-weekly schedule (30 versus 8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24441/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The role of chemotherapy in frail men (ie, those with an irreversible impairment) is less certain; an adapted treatment regimen may be considered. Chemotherapy is generally not indicated in men with terminal illness, and treatment is symptomatic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4113123\">",
"    <span class=\"h1\">",
"     SURVEILLANCE DURING AND AFTER TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance strategies during and after treatment for prostate cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10055?source=see_link&amp;anchor=H11088148#H11088148\">",
"     \"Follow-up surveillance during and after treatment for prostate cancer\", section on 'Metastatic prostate cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258749561\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of prostate cancer in elderly men requires careful assessment of multiple factors including comorbidities, dependency, activities of daily living, and nutritional status, which ultimately are more important than chronologic age. Based upon detailed assessment of these parameters, patients should be categorized as healthy, vulnerable with reversible problems, frail with irreversible problems, or terminal. A comprehensive geriatric assessment may be particularly useful for treatment planning in these men. (See",
"      <a class=\"local\" href=\"#H13013302\">",
"       'Patient classification'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=see_link\">",
"       \"Comprehensive geriatric assessment for patients with cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with localized prostate cancer, the choice of treatment depends on the assessment of patients overall status. (See",
"      <a class=\"local\" href=\"#H695146370\">",
"       'Treatment of localized disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Healthy elderly patients should have the same range of treatment options as for younger patients, including radical prostatectomy, radiation therapy (external beam",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      brachytherapy), and observation.",
"     </li>",
"     <li>",
"      Vulnerable patients with a reversible problem generally should receive the same treatment as for younger patients, excluding radical prostatectomy, with appropriate management of other underlying problems.",
"     </li>",
"     <li>",
"      Frail elderly men with a non-reversible problem should generally receive symptomatic management without definitive treatment (eg, initial hormone therapy).",
"     </li>",
"     <li>",
"      Terminal patients generally receive palliative treatment only.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with advanced disease are managed initially with hormone therapy (androgen deprivation therapy). Particular attention should be paid to the complications of androgen deprivation therapy and potential interactions with underlying comorbidities. (See",
"      <a class=\"local\" href=\"#H258747715\">",
"       'Hormone-sensitive prostate cancer'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"       \"Initial hormone therapy for metastatic prostate cancer\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=see_link\">",
"       \"Side effects of androgen deprivation therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with castrate-resistant prostate cancer can be candidates for cytotoxic chemotherapy, as in younger patients. The use of chemotherapy and the choice of regimen should incorporate information about the overall clinical status of the patient. (See",
"      <a class=\"local\" href=\"#H13013302\">",
"       'Patient classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H258747729\">",
"       'Castrate-resistant prostate cancer'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=see_link\">",
"       \"Chemotherapy in castrate-resistant prostate cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Horner M, Ries L, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006, based on November 2008 SEER data submission. In: National Cancer Institute; 2009.",
"    </li>",
"    <li>",
"     Ries, LAG, Melbert, D, Krapcho, M, et al. SEER Cancer Statistics Review, 1975&ndash;2005. Bethesda, MD: National Cancer Institute, 2008. Available at: file://seer.cancer.gov/csr/1975-2005/, based on December 2009 SEER data submission, posted to the SEER web site 2008.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/3\">",
"      Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin 2010; 60:120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/4\">",
"      Droz JP, Balducci L, Bolla M, et al. Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. Crit Rev Oncol Hematol 2010; 73:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/5\">",
"      Droz JP, Balducci L, Bolla M, et al. Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 2010; 106:462.",
"     </a>",
"    </li>",
"    <li>",
"     Senior Adult Oncology. In: NCCN Clinical Practice Guidelines in Oncology; 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/7\">",
"      Jeldres C, Latouff JB, Saad F. Predicting life expectancy in prostate cancer patients. Curr Opin Support Palliat Care 2009; 3:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/8\">",
"      Walz J, Gallina A, Perrotte P, et al. Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer. BJU Int 2007; 100:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/9\">",
"      Walz J, Suardi N, Shariat SF, et al. Accuracy of life tables in predicting overall survival in patients after radical prostatectomy. BJU Int 2008; 102:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/10\">",
"      Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007; 25:3576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/11\">",
"      Houterman S, Janssen-Heijnen ML, Verheij CD, et al. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer Prostatic Dis 2006; 9:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/12\">",
"      Konety BR, Cowan JE, Carroll PR, CaPSURE Investigators. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE. J Urol 2008; 179:1797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/13\">",
"      Bubolz T, Wasson JH, Lu-Yao G, Barry MJ. Treatments for prostate cancer in older men: 1984-1997. Urology 2001; 58:977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/14\">",
"      Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/15\">",
"      Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998; 280:975.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/16\">",
"      Cuzick J, Fisher G, Kattan MW, et al. Long-term outcome among men with conservatively treated localised prostate cancer. Br J Cancer 2006; 95:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/17\">",
"      Cooperberg MR, Cowan J, Broering JM, Carroll PR. High-risk prostate cancer in the United States, 1990-2007. World J Urol 2008; 26:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/18\">",
"      Ketchandji M, Kuo YF, Shahinian VB, Goodwin JS. Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc 2009; 57:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/19\">",
"      Alibhai SM, Naglie G, Nam R, et al. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol 2003; 21:3318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/20\">",
"      Konety BR, Sharp VJ, Raut H, Williams RD. Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus. Urology 2008; 71:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/21\">",
"      Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352:1977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/22\">",
"      Wong YN, Mitra N, Hudes G, et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men. JAMA 2006; 296:2683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/23\">",
"      Sun L, Caire AA, Robertson CN, et al. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. J Urol 2009; 182:2242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/24\">",
"      Magheli A, Rais-Bahrami S, Humphreys EB, et al. Impact of patient age on biochemical recurrence rates following radical prostatectomy. J Urol 2007; 178:1933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/25\">",
"      Siddiqui SA, Sengupta S, Slezak JM, et al. Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer. J Urol 2006; 175:952.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/26\">",
"      Malaeb BS, Rashid HH, Lotan Y, et al. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts. Urol Oncol 2007; 25:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/27\">",
"      Pierorazio PM, Humphreys E, Walsh PC, et al. Radical prostatectomy in older men: survival outcomes in septuagenarians and octogenarians. BJU Int 2010; 106:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/28\">",
"      Jeldres C, Suardi N, Walz J, et al. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. Eur Urol 2008; 54:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/29\">",
"      Tewari A, Johnson CC, Divine G, et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004; 171:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/30\">",
"      Kundu SD, Roehl KA, Eggener SE, et al. Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 2004; 172:2227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/31\">",
"      Stanford JL, Feng Z, Hamilton AS, et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/32\">",
"      Hoffman RM, Barry MJ, Stanford JL, et al. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am J Med 2006; 119:418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/33\">",
"      Mohamad BA, Marszalek M, Br&ouml;ssner C, et al. Radical prostatectomy in Austria: a nationwide analysis of 16,524 cases. Eur Urol 2007; 51:684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/34\">",
"      Hu JC, Elkin EP, Pasta DJ, et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004; 171:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/35\">",
"      Shikanov S, Desai V, Razmaria A, et al. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery. J Urol 2010; 183:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/36\">",
"      Greco KA, Meeks JJ, Wu S, Nadler RB. Robot-assisted radical prostatectomy in men aged &gt; or =70 years. BJU Int 2009; 104:1492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/37\">",
"      Gilbert SM, Kuo YF, Shahinian VB. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States. Urol Oncol 2011; 29:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/38\">",
"      D'Amico AV, Cote K, Loffredo M, et al. Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma. Cancer 2003; 97:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/39\">",
"      Dosoretz AM, Chen MH, Salenius SA, et al. Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapy. Cancer 2010; 116:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/40\">",
"      Jani AB, Gratzle J. Analysis of impact of age and race on biochemical control after radiotherapy in different prostate cancer settings. Urology 2005; 66:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/41\">",
"      Johnstone PA, Riffenburgh RH, Moul JW, et al. Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research. Int J Radiat Oncol Biol Phys 2003; 55:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/42\">",
"      D'Amico AV, Chen MH, Renshaw AA, et al. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 2008; 299:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/43\">",
"      Nguyen PL, Chen MH, Beard CJ, et al. Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence. Cancer 2010; 116:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/44\">",
"      Wo JY, Chen MH, Nguyen PL, et al. Evaluating the combined effect of comorbidity and prostate-specific antigen kinetics on the risk of death in men after prostate-specific antigen recurrence. J Clin Oncol 2009; 27:6000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/45\">",
"      Nanda A, Chen MH, Moran BJ, et al. Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy. Int J Radiat Oncol Biol Phys 2010; 77:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/46\">",
"      Hoffman KE, Chen MH, Moran BJ, et al. Prostate cancer-specific mortality and the extent of therapy in healthy elderly men with high-risk prostate cancer. Cancer 2010; 116:2590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/47\">",
"      Nanda A, Chen MH, Braccioforte MH, et al. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA 2009; 302:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/48\">",
"      Jani AB, Parikh SD, Vijayakumar S, Gratzle J. Analysis of influence of age on acute and chronic radiotherapy toxicity in treatment of prostate cancer. Urology 2005; 65:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/49\">",
"      Geinitz H, Zimmermann FB, Thamm R, et al. 3D conformal radiation therapy for prostate cancer in elderly patients. Radiother Oncol 2005; 76:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/50\">",
"      Villa S, Bedini N, Fallai C, Olmi P. External beam radiotherapy in elderly patients with clinically localized prostate adenocarcinoma: age is not a problem. Crit Rev Oncol Hematol 2003; 48:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/51\">",
"      Liu L, Glicksman AS, Coachman N, Kuten A. Low acute gastrointestinal and genitourinary toxicities in whole pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/52\">",
"      Schultheiss TE, Hanks GE, Hunt MA, Lee WR. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int J Radiat Oncol Biol Phys 1995; 32:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/53\">",
"      Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 2000; 47:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/54\">",
"      Chen AB, D'Amico AV, Neville BA, Earle CC. Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 2006; 24:5298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/55\">",
"      Pinkawa M, Fischedick K, Gagel B, et al. Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment. BMC Cancer 2009; 9:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/56\">",
"      Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177:2106.",
"     </a>",
"    </li>",
"    <li>",
"     NCCN Practice Guidelines in Oncology: Prostate Cancer file://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf (Accessed on August 09, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/58\">",
"      Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/59\">",
"      Stoch SA, Parker RA, Chen L, et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 2001; 86:2787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/60\">",
"      Bakhireva LN, Barrett-Connor E, Kritz-Silverstein D, Morton DJ. Modifiable predictors of bone loss in older men: a prospective study. Am J Prev Med 2004; 26:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/61\">",
"      Basaria S, Muller DC, Carducci MA, et al. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 2006; 106:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/62\">",
"      Braga-Basaria M, Dobs AS, Muller DC, et al. Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 2006; 24:3979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/63\">",
"      Harle LK, Maggio M, Shahani S, et al. Endocrine complications of androgen-deprivation therapy in men with prostate cancer. Clin Adv Hematol Oncol 2006; 4:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/64\">",
"      Kintzel PE, Chase SL, Schultz LM, O'Rourke TJ. Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer. Pharmacotherapy 2008; 28:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/65\">",
"      Leahy Y. Risk of metabolic syndrome, cardiovascular disease, and diabetes in androgen deprivation therapy. Clin J Oncol Nurs 2008; 12:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/66\">",
"      Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/67\">",
"      Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28:1769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/68\">",
"      Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 2006; 119:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/69\">",
"      Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of the \"androgen deprivation syndrome\" in men receiving androgen deprivation for prostate cancer. Arch Intern Med 2006; 166:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/70\">",
"      Loblaw DA, Virgo KS, Nam R, et al. Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2007; 25:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/71\">",
"      Berthold DR, Pond GR, Soban F, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study. J Clin Oncol 2008; 26:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/72\">",
"      Anderson J, Van Poppel H, Bellmunt J, et al. Chemotherapy for older patients with prostate cancer. BJU Int 2007; 99:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/73\">",
"      Begg CB, Carbone PP. Clinical trials and drug toxicity in the elderly. The experience of the Eastern Cooperative Oncology Group. Cancer 1983; 52:1986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/74\">",
"      Ritz P, Vellas B. Pharmacokinetics and drug toxicity in elderly patients: a case for geriatric core data in clinical trials. J Nutr Health Aging 2007; 11:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/75\">",
"      Beer TM, Berry W, Wersinger EM, Bland LB. Weekly docetaxel in elderly patients with prostate cancer: efficacy and toxicity in patients at least 70 years of age compared with patients younger than 70 years. Clin Prostate Cancer 2003; 2:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/76\">",
"      Italiano A, Ortholan C, Oudard S, et al. Docetaxel-based chemotherapy in elderly patients (age 75 and older) with castration-resistant prostate cancer. Eur Urol 2009; 55:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24441/abstract/77\">",
"      Foss&aring; SD. A randomized phase II trial comparing weekly taxotere plus prednisolone versus prednisolone alone in androgen-independent prostate cancer. Front Radiat Ther Oncol 2008; 41:108.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14257 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-CCB85E928E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24441=[""].join("\n");
var outline_f23_55_24441=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H258749561\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H695146355\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13013302\">",
"      PATIENT CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H695146363\">",
"      PROSTATE CANCER SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H695146370\">",
"      TREATMENT OF LOCALIZED DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258749388\">",
"      Impact of disease on survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258749381\">",
"      Organizational guidelines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H695146377\">",
"      Radical prostatectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13014038\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H695146384\">",
"      - Side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H695146391\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13014072\">",
"      - Disease control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13014089\">",
"      Side effects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H695146405\">",
"      Androgen deprivation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H695146339\">",
"      MANAGEMENT OF ADVANCED PROSTATE CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258747715\">",
"      Hormone-sensitive prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258747729\">",
"      Castrate-resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4113123\">",
"      SURVEILLANCE DURING AND AFTER TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258749561\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/14257\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/14257|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?9/5/9310\" title=\"figure 1\">",
"      SEER incidence prostate 2000 to 2006",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/14257|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/3/44093\" title=\"table 1\">",
"      Lawton daily living scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/40/26252\" title=\"table 2\">",
"      Charlson risk index",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?40/19/41277\" title=\"table 3\">",
"      TNM staging prostate CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/36/17996\" title=\"table 4\">",
"      Prob 10 year survival white men older than 70 RP prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32824?source=related_link\">",
"      Brachytherapy for localized prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/8/6280?source=related_link\">",
"      Chemotherapy in castrate-resistant prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/56/41864?source=related_link\">",
"      Comprehensive geriatric assessment for patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/47/23290?source=related_link\">",
"      External beam radiation therapy for localized prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10055?source=related_link\">",
"      Follow-up surveillance during and after treatment for prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/36/16969?source=related_link\">",
"      Initial approach to low-risk clinically localized prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=related_link\">",
"      Initial hormone therapy for metastatic prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/26/21930?source=related_link\">",
"      Initial management of regionally localized intermediate and high risk prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=related_link\">",
"      Overview of the treatment of disseminated prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9704?source=related_link\">",
"      Prostate cancer: Risk stratification, other prognostic factors, and predictive tools",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/47/24313?source=related_link\">",
"      Radical prostatectomy for localized prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/8/42122?source=related_link\">",
"      Screening for prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/30/21993?source=related_link\">",
"      Side effects of androgen deprivation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"./survival-estimates-in-advanced-terminal-cancer?source=related_link\">",
"      Survival estimates in advanced terminal cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_55_24442="Pulmonary atresia with intact ventricular septum (PA/IVS)";
var content_f23_55_24442=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary atresia with intact ventricular septum (PA/IVS)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24442/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24442/contributors\">",
"     David M Axelrod, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24442/contributors\">",
"     Stephen J Roth, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24442/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24442/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?23/55/24442/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?23/55/24442/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?23/55/24442/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H258049009\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary atresia with intact ventricular septum",
"    <span class=\"nowrap\">",
"     (PA/IVS)",
"    </span>",
"    is characterized by complete obstruction to right ventricular outflow with varying degrees of right ventricular and tricuspid valve hypoplasia. Blood is thus unable to flow from the right ventricle to the pulmonary artery and lungs, and an alternative source of pulmonary blood flow is required for survival. If untreated,",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is a uniformly fatal form of structural cardiac disease. Outcomes of surgical interventions are improving with a five-year survival rate of approximately 80 percent.",
"   </p>",
"   <p>",
"    The definition, anatomy, physiology, clinical presentation, management, including follow-up care, and outcome of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    will be reviewed",
"    <span class=\"nowrap\">",
"     here.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049016\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;PA/IVS",
"    is a rare congenital cardiac defect that consists of atresia of the pulmonary valve resulting in an absent connection between the right ventricular outflow tract (RVOT) and pulmonary arteries, and an intact ventricular septum that allows no connection between the right and left ventricles.",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is distinctive from pulmonary atresia with a ventricular septal defect",
"    <span class=\"nowrap\">",
"     (PA/VSD),",
"    </span>",
"    and from severe forms of Ebstein&rsquo;s anomaly of the tricuspid valve. Although all of these defects can result in complete obstruction of RVOT blood flow, they have different morphologic anatomic features (eg, right ventricular size and function, presence of pulmonary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tricuspid valve abnormalities, and status of the ventricular septum), which have an impact on management decisions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      features developmental abnormalities of the right ventricle and tricuspid valve that are &ldquo;upstream&rdquo; of the pulmonary outflow. The pulmonary arteries are small, but their architecture and branching are otherwise normal.",
"     </li>",
"     <li>",
"      Pulmonary atresia (PA) with a ventricular septal defect (VSD) more often features a normally-formed right ventricle and tricuspid valve with &ldquo;downstream&rdquo; abnormalities of the pulmonary artery architecture, in addition to the VSD.",
"     </li>",
"     <li>",
"      Ebstein&rsquo;s anomaly of the tricuspid valve is primarily characterized by abnormalities of the tricuspid valve and right ventricle, and is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/52/38729?source=see_link\">",
"       \"Ebstein's anomaly of the tricuspid valve\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H172915282\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported incidence of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    based on registries and population-based studies of children born with congenital heart disease is approximately four to eight per 100,000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/1-8\">",
"     1-8",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    accounts for 1 to 3 percent of all congenital cardiac defects in children. There is no difference in the incidence based on gender.",
"   </p>",
"   <p>",
"    However, these studies may underestimate the true incidence of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    because of spontaneous abortions (which may occur, especially if there is severe tricuspid regurgitation and hydrops fetalis) and elective termination (which may take place when an early diagnosis is made by fetal echocardiography) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049037\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is unknown. Compared with other cardiac lesions, identifiable genetic syndromes and other cardiac malformations are less common in",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"    Although there are isolated reports of familial cases of",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    including one publication that implicates a single gene [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/11,12\">",
"     11,12",
"    </a>",
"    ], evidence is insufficient to establish a consistent genetic association.",
"   </p>",
"   <p>",
"    It has been proposed that",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is an acquired lesion due to perturbation in fetal blood flow, based on reports of serial ultrasound studies showing the development of pulmonary atresia in fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. This theory has led to fetal interventions including in-utero dilation of the pulmonary valve to promote blood flow through the right ventricular outflow tract. (See",
"    <a class=\"local\" href=\"#H258049107\">",
"     'Fetal intervention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In some cases, it has been proposed that viral infection or inflammatory disease in mid-term gestation creates an atretic pulmonary valve and the subsequent abnormalities of fetal blood flow, resulting in",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"    However,",
"    <strong>",
"     no",
"    </strong>",
"    relationship has been established between",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    and maternal rubella, despite the reported associations between pulmonary stenosis and maternal rubella [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, pulmonary atresia with a ventricular septal defect",
"    <span class=\"nowrap\">",
"     (PA/VSD)",
"    </span>",
"    is thought to be an early gestational developmental lesion resulting from an abnormality in primary morphogenesis of the",
"    <span class=\"nowrap\">",
"     heart.",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049044\">",
"    <span class=\"h1\">",
"     ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;PA/IVS",
"    consists of a wide variety of anatomical cardiac defects that are associated with the primary lesion of pulmonary atresia. In 2000, the Congenital Heart Surgery Nomenclature and Database Project established a unified reporting system for right ventricular outflow tract (RVOT) obstruction that defined",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    as a duct-dependent congenital malformation with a spectrum of lesions, which include pulmonary atresia, variable degrees of hypoplasia of the right ventricle (RV) and tricuspid valve (TV), and anomalies of the coronary circulation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/18\">",
"     18",
"    </a>",
"    ]. Because of the diversity of anatomic findings, there is not a standard universal approach for",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    repair. Interventions (ie, biventricular, 1.5 ventricle, or univentricular repair) are based on the individual morphologic features of the RV, TV, and coronary artery circulations. (See",
"    <a class=\"local\" href=\"#H27930387\">",
"     'Repair'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049051\">",
"    <span class=\"h2\">",
"     Pulmonary valve atresia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    the underlying morphology of pulmonary atresia is either valvar (membranous) or muscular.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Valvar (membranous) pulmonary atresia &ndash; In most cases, the pulmonary valve is atretic with a small valve annulus, and identifiable but fused valve leaflets, which form a thin, intact membrane that causes RVOT obstruction [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/7,19\">",
"       7,19",
"      </a>",
"      ]. In these patients, the RV and infundibulum (funnel-shaped muscular structure that forms the RVOT below the pulmonary valve, also referred to as the conus arteriosus) are usually well developed.",
"     </li>",
"     <li>",
"      Muscular pulmonary atresia &ndash; In about 20 to 25 percent of patients, there is obliteration of the muscular infundibulum resulting, in muscular pulmonary atresia [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/7\">",
"       7",
"      </a>",
"      ]. Muscular pulmonary atresia is usually associated with severe right ventricular hypoplasia, increased risk and severity of coronary artery abnormalities, and poor outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5,20\">",
"       5,20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518116564\">",
"    <span class=\"h2\">",
"     Right ventricle",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is great variation in the morphology of the RV, ranging from a severely hypoplastic small cavity with marked muscular hypertrophy to a large, dilated, thin-walled chamber. This variation is due to the degree of intracavity muscular overgrowth. Normally, the RV is composed of three parts (tripartite): an inlet, a body (trabecular), and an outlet. The majority of patients with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    will have a well-formed tripartite RV (59 to 83 percent); others will have a bipartite RV due to apical trabecular overgrowth resulting in a small ventricle composed of an inlet and body, but no discernible outlet (15 to 34 percent); and a small number of patients will have a unipartite RV due to both infundibular and apical trabecular overgrowth, resulting in a severely hypoplastic RV with only a detectable inlet (2 to 8 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5,7\">",
"     5,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with a tripartite RV are more likely to be candidates for biventricular repair, as their RV can support full pulmonary blood flow. (See",
"    <a class=\"local\" href=\"#H27930387\">",
"     'Repair'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049058\">",
"    <span class=\"h2\">",
"     Tricuspid valve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The size of the TV is highly variable, and the valve is often small and dysplastic with stenosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    regurgitation. The size of the tricuspid annulus correlates with the size and morphology of the RV and the presence of coronary abnormalities, and is a factor in deciding on the choice of intervention (biventricular versus univentricular repair) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The TV size is compared to normal values and reported as a &ldquo;Z-score,&rdquo; which represents the number of standard deviations from the normal mean valve annulus size. Usually, a TV Z-score of -4 correlates with a unipartite ventricle, while a Z-score of -2 to 0 accompanies a tripartite ventricle. Z-scores of -4 to -2 are associated with variable degrees of RV hypoplasia. Both the TV Z-score and the RV size must be evaluated, as some studies show only moderate correlation between these measurements, and each are factors in determining whether patients are suitable candidates for biventricular repair [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a small minority of patients (4 to 10 percent), the TV may be inferiorly displaced in the RV, and is referred to as an Ebstein&rsquo;s (or Ebstenoid) anomaly of the TV [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/4,5,7\">",
"     4,5,7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/52/38729?source=see_link\">",
"     \"Ebstein's anomaly of the tricuspid valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049065\">",
"    <span class=\"h2\">",
"     Coronary arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the normal heart, the myocardium is predominantly perfused via diastolic flow from the aorta to the coronary arteries. In patients with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    abnormal connections between the RV and the coronary arteries are common due to the high pressure in the dysplastic right ventricular cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/7,21-23\">",
"     7,21-23",
"    </a>",
"    ]. Sinusoids, vascular pores within the ventricular myocardium that persist from fetal life, occur in about 70 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5\">",
"     5",
"    </a>",
"    ]. A fistula is a sinusoid that directly connects with a coronary artery, and the reported incidence of fistulae in patients with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    ranges from 50 to 70 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,7,22,24\">",
"     3,7,22,24",
"    </a>",
"    ]. Patients with a severely hypoplastic TV and a small, hypertensive RV are more likely to have fistulae [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,7,25,26\">",
"     3,7,25,26",
"    </a>",
"    ]. Fistulae between the RV and the coronary arteries may lead to proximal coronary stenoses or interruptions. Other coronary abnormalities include complete absence (atresia) of the aortocoronary connection, stenosis of the normally branching coronary arteries, or abnormal connections between the right and left coronary system.",
"   </p>",
"   <p>",
"    In about a quarter of cases, there is a right ventricular dependent coronary circulation (RVDCC), defined as coronary blood flow that is at least partially dependent upon retrograde blood flow from the RV [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5\">",
"     5",
"    </a>",
"    ]. RVDCC occurs when a communicating RV fistula arises in the presence of an atretic or stenotic coronary artery connection proximal to the RV-coronary connection, which prevents or limits the antegrade myocardial perfusion resulting in RVDCC [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3-5,7,24,27\">",
"     3-5,7,24,27",
"    </a>",
"    ]. Recognition of this clinical scenario is important, because RV decompression may lead to coronary artery steal, ischemia, infarction,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sudden cardiac death when the RVOT obstruction is relieved [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/23,27\">",
"     23,27",
"    </a>",
"    ]. Coronary arteries may receive blood flow only from the hypertensive RV, resulting in deoxygenated blood that delivers less oxygen to the myocardium compared with normal, fully oxygenated aortic blood flow. This may contribute to the long-term ventricular dysfunction that is associated with coronary abnormalities in patients with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on the above data, it is crucial that angiography is performed to identify and define any coronary artery abnormality and determine its potential impact both pre- and post-intervention on myocardial perfusion. (See",
"    <a class=\"local\" href=\"#H597292146\">",
"     'Cardiac catheterization'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518116525\">",
"    <span class=\"h2\">",
"     Pulmonary circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pulmonary circulation is usually supported with a normal, left-sided patent ductus arteriosus connecting to confluent pulmonary arteries that exhibit a normal branching pattern from the main pulmonary trunk. Rarely, patients with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    have abnormal development of the pulmonary arteries and connections from the aorta to the pulmonary arteries called major aortopulmonary collateral arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/28\">",
"     28",
"    </a>",
"    ]. While gross anatomic abnormalities of the pulmonary arterial tree are uncommon, one histologic study of the pulmonary arteries in",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    revealed significant medial and intimal abnormalities, possibly related to ductal-dependent pulmonary blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H535752701\">",
"    <span class=\"h2\">",
"     Other anatomic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other less common anatomic defects may affect the left ventricle, aortic valve, and right atrium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H535752708\">",
"    <span class=\"h3\">",
"     Left ventricle and aortic valve",
"    </span>",
"    &nbsp;&mdash;&nbsp;The left heart may exhibit aortic stenosis or a bicuspid aortic valve. The morphology of the left ventricle (LV) is usually normal, but the LV function may be affected by coronary insufficiency, which can be exacerbated by chronic perfusion of cyanotic blood from the RV leading to further coronary insufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/30\">",
"     30",
"    </a>",
"    ]. A mild or moderate obstruction of the LV outflow tract by the hypertrophied interventricular septum has also been described in about 45 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H535752715\">",
"    <span class=\"h3\">",
"     Right atrium",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to tricuspid regurgitation, the right atrium may be enlarged, sometimes compressing the right lung. Usually a patent foramen ovale (PFO) or atrial septal defect exists to allow egress of blood from the right to the left atrium; a pressure-restrictive PFO is rare and most often leads to fetal demise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H291329\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    pulmonary atresia causes right ventricular outflow tract (RVOT) obstruction. With an intact ventricular septum, there are only two ways for blood to exit the right ventricle (RV): via tricuspid regurgitation back into the right atrium, and through connections between the RV and the coronary artery circulation (ie, fistulae and sinusoids) (see",
"    <a class=\"local\" href=\"#H258049065\">",
"     'Coronary arteries'",
"    </a>",
"    above). Return of blood to the systemic circulation is primarily dependent on blood flow from the right atrium through the foramen ovale into the left atrium, and subsequently, the left ventricle. In addition, blood passing out of the RV via sinusoids is returned to the systemic circulation through the coronary circulation.",
"   </p>",
"   <p>",
"    RV pressure is dependent on the extent of the RV egress. In cases with limited tricuspid regurgitation and coronary circulation egress, RV pressure increases and may rise to supra-systemic levels, in some cases as high as 200 mmHg. In contrast, in patients with free tricuspid regurgitation, the RV pressure may be nearly normal with a significant amount of blood returned to the right atrium followed by flow into the left atrium across a patent foramen ovale.",
"   </p>",
"   <p>",
"    In neonates with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    the ductus arteriosus is small compared with normal infants, as fetal blood flow from the pulmonary artery through the ductus arteriosus is limited due to RVOT obstruction. However, after birth, a patent ductus arteriosus is crucial for survival, as it is the sole source of pulmonary blood supply. (See",
"    <a class=\"local\" href=\"#H597292176\">",
"     'Initial stabilization'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049086\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518116982\">",
"    <span class=\"h2\">",
"     Fetal presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in ultrasound technology have enabled routine antenatal screening at 18 and 22 weeks gestation to establish an accurate fetal diagnosis. Features of critical pulmonary obstruction may be observed in some fetuses as early as 12 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H518118050\">",
"     'Fetal diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518117018\">",
"    <span class=\"h2\">",
"     Postnatal presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neonates with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    present with cyanosis due to an obligate right-to-left shunt at the atrial level [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5\">",
"     5",
"    </a>",
"    ]. Although infants may have mild tachypnea or hyperpnea, severe respiratory distress is uncommon and differentiates these patients from those with cyanosis due to a pulmonary cause (eg, neonatal respiratory distress syndrome). In addition, these infants generally have a benign fetal and birth history.",
"   </p>",
"   <p>",
"    If untreated,",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is an almost uniformly fatal disease; approximately 50 percent of children will die within two weeks of birth and 85 percent by six months [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/32\">",
"     32",
"    </a>",
"    ]. Because",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is a ductal-dependent lesion, closure of the patent ductus arteriosus (PDA) generally results in rapid clinical deterioration and life-threatening consequences, including severe metabolic acidosis and hypoxemia, seizures, cardiogenic shock, cardiac arrest, and death. Rarely, prolonged survival can occur with pulmonary blood flow maintained by a persistent PDA or systemic artery to pulmonary artery blood flow via one or more collateral blood vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H291329\">",
"     'Pathophysiology'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33482?source=see_link&amp;anchor=H270523895#H270523895\">",
"     \"Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD\", section on 'Ductal dependent lesions, delayed diagnosis, and death'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518118023\">",
"    <span class=\"h3\">",
"     Physical findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to cyanosis, other physical findings may include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Single second heart sound due to a single semilunar valve (the aortic valve).",
"     </li>",
"     <li>",
"      Systolic murmur due to tricuspid regurgitation.",
"     </li>",
"     <li>",
"      Right ventricular (RV) precordial impulse is not hyperdynamic because of the small volume of blood entering the hypoplastic RV.",
"     </li>",
"     <li>",
"      Less commonly, a continuous &ldquo;machinery type&rdquo; murmur due to a PDA.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518117107\">",
"    <span class=\"h3\">",
"     Tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients will undergo initial testing that includes pulse oximetry screening, chest radiography, electrocardiography, and laboratory testing. However, the diagnosis is typically made by echocardiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518117137\">",
"    <span class=\"h4\">",
"     Pulse oximetry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulse oximetry reveals desaturation consistent with the physical findings of cyanosis (",
"    <a class=\"graphic graphic_table graphicRef75461 \" href=\"UTD.htm?10/61/11228\">",
"     table 1",
"    </a>",
"    ). The systemic oxygen saturation depends on the amount of left-to-right shunt from the aorta to the pulmonary arteries via the PDA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H87807098#H87807098\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Oxygen saturation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518117152\">",
"    <span class=\"h4\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest radiograph usually exhibits a normal or enlarged cardiac silhouette with normal pulmonary vascular markings in the neonate (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88537 \" href=\"UTD.htm?13/21/13652\">",
"     image 1",
"    </a>",
"    ). If there is significant tricuspid regurgitation with an Ebstein&rsquo;s type tricuspid valve, the chest radiograph may demonstrate marked right atrial and ventricular enlargement resulting in a large cardiac silhouette (cardiomegaly).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518117159\">",
"    <span class=\"h4\">",
"     Electrocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The electrocardiogram (ECG) reveals a QRS axis of 0 to +90, with decreased right-sided ventricular forces that correlate with increasing severity of RV hypoplasia (",
"    <a class=\"graphic graphic_waveform graphicRef88539 \" href=\"UTD.htm?1/33/1561\">",
"     waveform 1",
"    </a>",
"    ). The normal right axis deviation of a newborn is usually absent, and right atrial enlargement may be present. Therefore, relative left axis deviation in a cyanotic newborn should prompt the clinician to consider",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    in the differential diagnosis.",
"   </p>",
"   <p>",
"    Other findings include tall P waves due to right atrial enlargement in the setting of significant tricuspid regurgitation, and abnormal ST segments and T waves may reflect subendocardial ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518117882\">",
"    <span class=\"h4\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing is",
"    <strong>",
"     not",
"    </strong>",
"    helpful, as results are not specific to",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    and are similar to those seen in other cyanotic congenital heart defects. Specifically, arterial blood gas sampling reveals hypoxemia with partial pressure of arterial oxygen (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) levels typically 35 to 45 mmHg (depending on the amount of pulmonary blood flow) and the fractional inspired oxygen concentration (",
"    <a class=\"graphic graphic_table graphicRef75461 \" href=\"UTD.htm?10/61/11228\">",
"     table 1",
"    </a>",
"    ). A hyperoxia challenge will usually reveal a PaO",
"    <sub>",
"     2",
"    </sub>",
"    less than 100 mmHg, indicating obligate intracardiac right-to-left shunting rather than primary lung disease (",
"    <a class=\"graphic graphic_table graphicRef54070 \" href=\"UTD.htm?16/41/17053\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H87808016#H87808016\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Arterial blood gas'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H21#H21\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Hyperoxia test'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518118043\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518118050\">",
"    <span class=\"h2\">",
"     Fetal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine obstetric screening with ultrasound using a four-chamber view of the heart in the fetus can make a diagnosis of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    during the second trimester (18 to 22 weeks gestation). The characteristic findings of an atretic pulmonary valve and a hypoplastic tricuspid valve (TV) and right ventricle (RV) are key diagnostic features. In addition, fetal echocardiography may also note reversed ductal flow (from aorta to pulmonary artery) with a &ldquo;vertically oriented&rdquo; ductus arteriosus, which contrasts with the normal venous blood flow from the RV through a horizontally-positioned ductus arteriosus to the descending aorta. Prenatal imaging of coronary artery abnormalities has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Retrospective studies reviewing fetal echocardiographic findings and patient outcome have identified factors (eg, absence of tricuspid regurgitation) that may be associated with poor outcome and those that may be used to guide management decisions (eg, biventricular versus univentricular repair) [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/37-42\">",
"     37-42",
"    </a>",
"    ]. This information, including ongoing validation of the diagnosis, may assist in parental counseling and education, and management decisions such as consideration of pregnancy termination or planned delivery at a tertiary medical center with experience in managing complex congenital heart disease (CHD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H518118251\">",
"    <span class=\"h2\">",
"     Postnatal diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postnatal diagnosis of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is generally confirmed by echocardiography. Echocardiography is performed based on a strong clinical suspicion for CHD because of signs and symptoms of cyanotic CHD (eg, cyanosis without marked respiratory distress) and physical findings suggestive of cardiac disease (eg, single second heart sound and cardiac murmur).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292087\">",
"    <span class=\"h3\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The echocardiographic diagnosis is made by identifying the atretic pulmonary valve with pulse-wave Doppler sampling of the pulmonary valve to confirm a lack of RV outflow, and differentiating between critical pulmonary stenosis and true pulmonary atresia, and an intact ventricular septum (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88540 \" href=\"UTD.htm?21/61/22488\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292094\">",
"    <span class=\"h1\">",
"     FURTHER EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further evaluation consists of additional echocardiographic imaging and cardiac catheterization to help inform decisions regarding intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292101\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to confirming the diagnosis of",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    echocardiography provides information regarding the size and function of the right ventricle (RV) and tricuspid valve (TV), and evaluates the adequacy of intracardiac mixing and pulmonary blood flow.",
"   </p>",
"   <p>",
"    The evaluation includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Assess size and function of the RV, including determining if RV morphology is uni-, bi-, or tripartite (see",
"      <a class=\"local\" href=\"#H518116564\">",
"       'Right ventricle'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Measure the TV size and compare with normal values using Z-score (see",
"      <a class=\"local\" href=\"#H258049058\">",
"       'Tricuspid valve'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Assess intracardiac mixing and pulmonary blood flow by measuring blood flow through the patent foramen ovale and ductus arteriosus.",
"     </li>",
"     <li>",
"      Assess left ventricular function, status of the aortic valve, and left outflow tract.",
"     </li>",
"     <li>",
"      If possible, detection of coronary artery abnormalities, which are suggested by abnormal continuous flow seen in the sinusoids or fistulae of the RV. Proximal coronary artery origins should be confirmed at the sinuses of Valsalva of the aorta. However, angiography is needed to provide a more complete evaluation of the coronary system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292146\">",
"    <span class=\"h2\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac catheterization is essential to identify coronary abnormalities, which is an important factor in the management of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88541 \" href=\"UTD.htm?35/5/35926\">",
"     image 3",
"    </a>",
"    ). Coronary sinusoids and fistulae are diagnosed by injection of contrast into the RV, and proximal coronary artery atresia and coronary stenoses are visualized by selective injection of the coronary artery origins from the aorta. It is important to determine whether coronary arterial perfusion is dependent on circulation from the RV (ie, right ventricular dependent coronary circulation), as decompression of the RV during surgery could lead to coronary artery steal, ischemia, infarction, cardiac arrest,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    death [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/21,24,27,43\">",
"     21,24,27,43",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H258049065\">",
"     'Coronary arteries'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    RV size and morphology, and TV size are also confirmed by angiography. Hemodynamic measurements may reveal a severely hypertensive RV in the smallest unipartite ventricles with little tricuspid regurgitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292183\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    includes other cyanotic cardiac conditions with right ventricular outlet obstruction, which typically have radiographic features of a normal to mildly enlarged heart and normal pulmonary vascular markings.",
"   </p>",
"   <p>",
"    Echocardiography distinguishes",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    from the following cardiac diseases:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pulmonary atresia with ventricular septal defect",
"     </li>",
"     <li>",
"      Critical pulmonary stenosis",
"     </li>",
"     <li>",
"      Tetralogy of Fallot (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13752?source=see_link&amp;anchor=H13#H13\">",
"       \"Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot\", section on 'Diagnosis'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Tricuspid atresia",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049093\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292169\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is challenging because a uniform approach is not feasible given the heterogeneity of anatomic findings, especially the wide spectrum of abnormalities of the right ventricle (RV) and tricuspid valve (TV). In addition, long-term outcome data are limited and it is still difficult to predict the effect of interventions, especially biventricular repair, performed early in life on RV growth and function through adulthood.",
"   </p>",
"   <p>",
"    Neonates with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    should be cared for at a tertiary medical center with experience in managing complex congenital heart disease (CHD). When an antenatal diagnosis is made, maternal transfer should be performed so that neonatal care can be given immediately after birth.",
"   </p>",
"   <p>",
"    The management of",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    includes initial stabilization followed by corrective or palliative repair.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Initial stabilization includes administration of prostaglandin E1 (alprostadil) to maintain patency of the ductus arteriosus, which typically provides the sole source of pulmonary blood flow, and cardiorespiratory support.",
"     </li>",
"     <li>",
"      Subsequent management is based on assessing whether a patient is a better candidate for biventricular (corrective) repair, 1.5 ventricle repair, univentricular (palliative) repair, or in the severest cases, primary cardiac transplantation. Interventional options include catheter-based or surgical procedures.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H597292176\">",
"    <span class=\"h2\">",
"     Initial stabilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial management is focused on stabilization of cardiac and pulmonary function, and ensuring adequate systemic oxygenation. The goal of initial treatment is to stabilize and optimize the neonate&rsquo;s condition so that corrective or palliative repair can be performed.",
"   </p>",
"   <p>",
"    Therapy is directed towards providing sufficient intercirculatory mixing by maintaining patency of the ductus arteriosus with prostaglandin E1 (alprostadil) infusion. Similarly, the cardiac output is dependent on blood shunting from the right to the left atrium. A severely restrictive atrial communication would likely result in spontaneous abortion and is rare in newborns with",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"    Some centers perform balloon atrial septostomy to improve right-to-left atrial shunting, especially in patients who will eventually require an aortopulmonary shunt [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H27#H27\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Prostaglandin E1'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H28#H28\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Cardiac catheterization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Initial management also includes general cardiorespiratory support for infants with respiratory compromise, hypotension, poor perfusion, acidosis, and hypothermia. These measures include respiratory support (eg, supplemental oxygen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mechanical ventilation), inotropic agents, and correction of acidosis and metabolic derangements (eg, hypoglycemia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H25#H25\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'General supportive care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27930387\">",
"    <span class=\"h2\">",
"     Repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following are options for corrective or palliative repair for patients with",
"    <span class=\"nowrap\">",
"     PA/IVs.",
"    </span>",
"    The choice of repair and implementation are best done under the direction of a multidisciplinary team of pediatric cardiologists and cardiothoracic surgeons, as these repairs typically involve a series of both catheter-based and surgical procedures.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biventricular repair &ndash; Repair to separate pulmonary and systemic circulations with two pumping ventricles.",
"     </li>",
"     <li>",
"      Univentricular repair &ndash; Repair to separate pulmonary and systemic circulations with only one pumping ventricle (ie, left ventricle).",
"     </li>",
"     <li>",
"      Hybrid (1.5 ventricle) repair &ndash; Repair to separate pulmonary and systemic circulations with two pumping ventricles, but the RV is not capable of totally supporting the pulmonary circulation alone. In this repair, the Glenn operation provides a direct source of pulmonary blood flow from the superior vena cava, while the inferior vena cava blood flow is pumped through the RV and reconstructed pulmonary valve [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/44\">",
"       44",
"      </a>",
"      ]. When subsequent RV growth is sufficient to fully support the pulmonary circulation, catheter-based closure of the patent foramen ovale",
"      <span class=\"nowrap\">",
"       (PFO)/atrial",
"      </span>",
"      septal defect (ASD) can be performed. However, when there is",
"      <strong>",
"       not",
"      </strong>",
"      satisfactory RV growth over time, the 1.5 ventricle repair is the definite palliative operation in patients who can maintain adequate oxygenation and cardiac output with this physiology.",
"     </li>",
"     <li>",
"      Patients with aortocoronary atresia have a mortality rate approaching 100 percent, even with palliative surgical repair, leading most centers to offer these patients primary cardiac transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on these options, patient management is determined by the feasibility of biventricular repair and depends on the morphologic features of the individual patient [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,4,45,46\">",
"     3,4,45,46",
"    </a>",
"    ]. The following general questions are useful in determining the feasibility of biventricular repair:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Can the RV be rehabilitated so that it can fully support the pulmonary circulation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/47\">",
"       47",
"      </a>",
"      ]?",
"     </li>",
"     <li>",
"      Are coronary artery abnormalities present and can the RV be decompressed during repair? In other words, does this patient have right ventricular dependent coronary circulation (RVDCC), and could decompression of the RV result in &ldquo;coronary steal&rdquo; and potentially cardiac death [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/27\">",
"       27",
"      </a>",
"      ]?",
"     </li>",
"     <li>",
"      Is there a tripartite RV with membranous atresia of the pulmonary valve?",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, it is challenging to answer all these questions accurately because of the complexity and heterogeneity of this lesion, which has led to variability among institutions regarding the choice of intervention. In order to provide accurate answers based on measurable morphologic findings, several studies have reviewed outcome data to identify factors that predict the success of biventricular repair. These factors include size of the TV and RV, ratio of the tricuspid to mitral valve size, RV morphology (ie, uni-, bi-, tripartite RV), or the presence of coronary artery abnormalities, particularly the presence of RVDCC as illustrated by the following studies [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,4,27,45,46,48\">",
"     3,4,27,45,46,48",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a large multicenter study of 408 neonates with",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      from the Congenital Heart Surgeons Study, multivariable analysis identified birth weight, TV size (Z-score), degree of tricuspid regurgitation, and the presence of RVDCC as determinants of the type of surgical repair [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. In this cohort, 38 percent of patients died before definite repair could be performed. In the remaining patients, biventricular, univentricular, hybrid repair, and cardiac transplantation were performed in 33, 20, 5 and 2 percent of patients, respectively. Two percent of patients were awaiting definitive repair at the end of follow-up.",
"     </li>",
"     <li>",
"      In single-center studies, biventricular repair rates were reported between 38 to 50 percent in patients who underwent definitive repair [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5,45,49\">",
"       5,45,49",
"      </a>",
"      ]. Biventricular repair was associated with larger TV size, a tripartite or near normal-size RV, and the absence of coronary fistulae.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H121819659\">",
"    <span class=\"h3\">",
"     Our approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;At our institution, the management of newborns with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    is a collaborative medical and surgical effort. Decision making is based on anatomical and physiologic data of the lesion for each individual patient to determine whether biventricular repair is feasible.",
"   </p>",
"   <p>",
"    The following postnatal evaluation provides morphologic data that help inform management decisions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Echocardiography measures the size of the TV (Z-score), and the size and morphology of the RV (uni-, bi-, or tripartite).",
"     </li>",
"     <li>",
"      Cardiac catheterization is performed on virtually all patients with",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      to identify right ventricular coronary connections and look for the presence of RVDCC [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/21,24,27,43\">",
"       21,24,27,43",
"      </a>",
"      ]. Rarely, cardiac catheterization is not performed in select patients due to extreme prematurity and who have very small RVs (Z scores between -3 and -5, which will necessitate a surgical systemic-to-pulmonary shunt regardless of catheterization findings).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The choice of intervention for each patient is centered on the TV Z-score, coronary artery anatomy and perfusion, and RV size, as we believe these parameters are the most useful in determining the success of biventricular repair based on the currently available evidence [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,4,27,45,46,48-50\">",
"     3,4,27,45,46,48-50",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with a TV Z-score less than -4 or with RVDCC typically undergo palliative univentricular repair. In these patients, staged surgery towards a Fontan procedure provides adequate systemic-to-pulmonary blood flow. Rarely, the patent ductus arteriosus (PDA) is stented during catheterization to provide pulmonary blood flow. This approach is similar to that used in patients with other univentricular conditions, such as hypoplastic left heart syndrome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41401?source=see_link&amp;anchor=H18895239#H18895239\">",
"       \"Hypoplastic left heart syndrome\", section on 'Surgical management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients who have a borderline-sized RV, TV Z-score between -4 to -2, and no RVDCC usually undergo a hybrid (1.5 ventricle) repair [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/5,51-55\">",
"       5,51-55",
"      </a>",
"      ]. This repair consists of opening the right ventricular outflow tract (RVOT), creating a bidirectional cavopulmonary anastomosis (Glenn shunt), and partial closure of the patent foramen ovale (PFO). By diverting superior vena cava blood directly to the lungs through the Glenn shunt, the small RV is &ldquo;volume unloaded&rdquo; and better able to pump IVC blood through the surgically-opened pulmonary valve. Data from small studies suggest that flow through the TV stimulates growth of right heart structures if the outflow obstruction to the pulmonary artery is relieved [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/47\">",
"       47",
"      </a>",
"      ]. Hemodynamic catheterization is then repeated at one to three years to determine if the right heart is adequate for complete closure of the",
"      <span class=\"nowrap\">",
"       PFO/ASD,",
"      </span>",
"      or if a single ventricle palliation via the Fontan procedure is required.",
"     </li>",
"     <li>",
"      For patients with a borderline or adequately-sized TV (Z-score &ge;-2) without RVDCC, biventricular repair is the long-term goal. The initial step is decompression of the RV by reconstructing the RVOT either by surgical or catheter-based intervention [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,56,57\">",
"       3,56,57",
"      </a>",
"      ]. The goal of RVOT decompression is to promote RV and TV growth [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/58\">",
"       58",
"      </a>",
"      ], so that the right side of the heart will eventually be able to pump a full cardiac output to the lungs:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The RVOT may be opened surgically with a patch across the pulmonary valve annulus (&ldquo;transannular patch&rdquo;)",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulmonary valvotomy.",
"     </li>",
"     <li>",
"      Alternatively, the RVOT may be opened during catheterization with radiofrequency perforation in patients with a tripartite RV and membranous valve atresia [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/59,60\">",
"       59,60",
"      </a>",
"      ]",
"      <strong>",
"       .",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    After RVOT decompression, additional intervention (eg, catheter-based stenting of the ductus arteriosus or surgical creation of systemic-to-pulmonary shunts), which results in a hybrid repair, may be needed to provide adequate pulmonary blood flow and oxygenation until RV growth is adequate [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/56,59-63\">",
"     56,59-63",
"    </a>",
"    ]. Subsequent cardiac catheterization is performed to assess RV function. If the RV is adequate as the sole source of pulmonary blood flow and the atrial pressure is not elevated, the",
"    <span class=\"nowrap\">",
"     PFO/ASD",
"    </span>",
"    and systemic-to-pulmonary shunt may be closed by catheter-delivered occlusion devices, thereby completing the bi-ventricular repair. Patients who do not require subsequent procedures usually have significantly larger tricuspid valves (based on Z-score) and tripartite right ventricles [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049107\">",
"    <span class=\"h2\">",
"     Fetal intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antenatal therapies to treat",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    have been developed in centers that specialize in fetal cardiac intervention. Proponents of fetal intervention suggest that halting the development of pulmonary atresia would allow for continued growth of &ldquo;upstream&rdquo; structures, namely the RV and TV. Although small case series demonstrate that in-utero dilation of the pulmonary valve is feasible, it still is unclear whether this intervention will prove to be beneficial or not [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/64-66\">",
"     64-66",
"    </a>",
"    ]. In one case series of 10 fetuses with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    balloon dilation was technically unsuccessful in the first four attempts, but was successfully performed in the latter six cases [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/64\">",
"     64",
"    </a>",
"    ]. Nine of the 10 fetuses progressed to term delivery and were alive at follow-up (range 0.5 to 5.8 years), and one pregnancy was terminated after an unsuccessful intervention. In the six fetuses with successful intervention, there was increased growth of the tricuspid and pulmonary annuli and RV compared with control fetuses with",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"    Four of the six patients underwent biventricular repair, one with a hybrid repair, and the sixth patient, who had a very small RV and RVDCC, underwent univentricular repair.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049114\">",
"    <span class=\"h1\">",
"     OUTCOMES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049121\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although pulmonary atresia with intact ventricular septum",
"    <span class=\"nowrap\">",
"     (PA/IVS)",
"    </span>",
"    continues to be challenging to treat for surgeons and cardiologists, outcomes have improved as experience with the spectrum of anatomic findings has broadened. Large, multi-institutional studies report an overall survival of approximately 80 percent at one month and 60 percent at 10 to 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/3,4,7\">",
"     3,4,7",
"    </a>",
"    ]. Survival in these studies improved over time, with later-era patients achieving 80 percent survival at five years [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363262645\">",
"    <span class=\"h3\">",
"     Biventricular repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term survival approaches 90 percent in studies using a",
"    <strong>",
"     selective",
"    </strong>",
"    management approach, which results in fewer patients receiving biventricular repair, as illustrated by the following case series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a Japanese case series of 73 patients with",
"      <span class=\"nowrap\">",
"       PA/IVS,",
"      </span>",
"      the 20-year survival rate was 91 percent in 23 patients who underwent biventricular repair [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/67\">",
"       67",
"      </a>",
"      ]. Patients with biventricular repair had a tripartite RV and did",
"      <strong>",
"       not",
"      </strong>",
"      have any major coronary arterial sinusoidal communications. In addition, the reintervention-free and arrhythmia-free rates at 20-year follow-up for patients with biventricular repair were 75 and 50 percent, respectively. Long-term complications included dilatation of the RV due to tricuspid regurgitation (TR) and pulmonary regurgitation (PR), which contributed to the development of cardiac arrhythmias. Two patients received tricuspid valve replacement because of severe RV dilation and refractory atrial tachyarrhythmias.",
"     </li>",
"     <li>",
"      In a case series from the United States, the five-year survival rate of 26 of 56 patients who underwent a partial or complete biventricular repair was 92 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/43\">",
"       43",
"      </a>",
"      ]. All patients required reoperation at a median duration of 6.9 years including early intervention for wound infection (35 percent) and late reoperation for pulmonary valve (PV) replacement (59 percent).",
"     </li>",
"     <li>",
"      In a German case series of 86 patients with",
"      <span class=\"nowrap\">",
"       PA/IVS,",
"      </span>",
"      the 25-year survival rate for the 56 patients who underwent biventricular repair was 80 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/47\">",
"       47",
"      </a>",
"      ]. Patients with biventricular repair were more likely to have undergone RV decompression, have a tripartite RV, and have",
"      <strong>",
"       no",
"      </strong>",
"      coronary artery fistulae.",
"     </li>",
"     <li>",
"      Another case series, which included 12 patients with biventricular repair and one with hybrid repair, also reported late complications of significant PR and RV dilation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/68\">",
"       68",
"      </a>",
"      ]. In this cohort of patients, PV replacement was successfully performed resulting in a reduction in PR and RV end-diastolic volume, but significant TR recurred after PV replacement.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049128\">",
"    <span class=\"h3\">",
"     Univentricular repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who underwent univentricular repair with the Fontan procedure have a reported survival of approximately 80 percent at 5 to 15 year follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/69-71\">",
"     69-71",
"    </a>",
"    ], a rate that is comparable for patients who undergo single ventricle palliation for other congenital heart defects. Limited data suggest that patients with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    who undergo Fontan procedures are at risk for death due to coronary artery ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363262857\">",
"    <span class=\"h3\">",
"     Hybrid repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients repaired with a hybrid (1.5 ventricle) approach may achieve satisfactory results with 90 percent survival at five years; 95 percent of survivors are classified as NYHA class I or II [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/44,52,53\">",
"     44,52,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049149\">",
"    <span class=\"h2\">",
"     Quality of life",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data on the quality of life for with",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"    Preliminary results from a follow-up study of 102 patients from the Congenital Heart Surgeons Society study reported reduced physical functional health status and measured exercise capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a Swedish survey of 52 patients with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    there were no overall differences in the response of 42 patients and parents compared with a healthy group of children to a quality of life questionnaire [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/73\">",
"     73",
"    </a>",
"    ]. However, other studies report a decrease in exercise capacity in patients with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    especially those who undergo uni- or 1.5 ventricular repair, suggesting that this may have an impact on overall activity [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/74-78\">",
"     74-78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although there are no specific data on neurodevelopmental outcome for patients with",
"    <span class=\"nowrap\">",
"     PA/IVS,",
"    </span>",
"    children who have had cardiac surgery frequently exhibit abnormal neurodevelopment and require developmental evaluation and assistance [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/79-82\">",
"     79-82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049156\">",
"    <span class=\"h1\">",
"     HEALTH CARE MAINTENANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;As for all patients with repaired or palliated congenital heart disease, long-term health care maintenance is a collaborative effort between primary care and pediatric cardiology clinicians. Guidelines for the outpatient management of patients with repaired and palliated congenital heart disease exist [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/83\">",
"     83",
"    </a>",
"    ], although not specifically for",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"   </p>",
"   <p>",
"    At",
"    each health maintenance visit, patients should be evaluated for the following [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/84\">",
"     84",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Symptoms of fatigue or dyspnea may be suggestive of heart failure.",
"     </li>",
"     <li>",
"      Symptoms of palpitation or syncope may be suggestive of cardiac arrhythmias.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Physical examination",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Vital signs should include measurement of systemic oxygen saturation (SpO",
"      <sub>",
"       2",
"      </sub>",
"      ). This is especially important in patients with uni- or 1.5 ventricular repair who have intracardiac shunts to ensure adequate oxygenation (SpO",
"      <sub>",
"       2",
"      </sub>",
"      should be greater than 90 percent).",
"     </li>",
"     <li>",
"      Evidence of right-sided heart failure (eg, hepatomegaly or peripheral edema).",
"     </li>",
"     <li>",
"      Cardiac auscultation, particularly murmurs that suggest tricuspid regurgitation, and pulmonary stenosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      regurgitation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Electrocardiography to detect any evidence of arrhythmias, ischemic changes, or right atrial hypertrophy",
"     </li>",
"     <li>",
"      Chest radiography to assess right-sided anatomy, particularly evidence of RV dilatation",
"     </li>",
"     <li>",
"      Echocardiography",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In patients with biventricular repair, assess right ventricular size and function, and size and function of the tricuspid and pulmonary valves.",
"     </li>",
"     <li>",
"      In patients with univentricular repair, detect any evidence of atrial obstruction or thrombus, and evaluate the status of intracardiac shunts.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other studies may be indicated including cardiac catheterization, magnetic resonance imaging, and nuclear scintography for further delineation of the hemodynamic status of the heart and intracardiac shunts, coronary artery anatomy, and cardiac perfusion.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following medical concerns are associated with the specific repair [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/84\">",
"     84",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biventricular repair &ndash; Although many patients will be well with minimal effects, a significant number of patients may have residual pulmonary stenosis, and tricuspid",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulmonary regurgitation [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/47,67,68\">",
"       47,67,68",
"      </a>",
"      ]. In addition, atrial arrhythmias may occur in patients with right atrial dilatation due to tricuspid",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulmonary regurgitation.",
"     </li>",
"     <li>",
"      Univentricular repair &ndash; Long-term complications are similar to patients who underwent Fontan procedure for other conditions including atrial arrhythmias, cyanosis, right atrial thrombosis, and cardiac ischemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41401?source=see_link&amp;anchor=H70091519#H70091519\">",
"       \"Hypoplastic left heart syndrome\", section on 'Morbidity'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363263346\">",
"    <span class=\"h2\">",
"     Activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no specific published guidelines for patients with",
"    <span class=\"nowrap\">",
"     PA/IVS.",
"    </span>",
"    However, activity recommendations can be inferred from guidelines for other similar cardiac lesions following either complete or palliative repair [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/85,86\">",
"     85,86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with biventricular repair with minimal residual effects - Similar to those who are postoperative with tetralogy of Fallot or transposition of the great arteries, these patients with normal ventricular function, normal exercise test, and no arrhythmias can participate in all sports.",
"     </li>",
"     <li>",
"      The guidelines for patients who are postoperative Fontan procedure (univentricular repair) generally limit participation to class IA, low-intensity competitive sports (",
"      <a class=\"graphic graphic_figure graphicRef64493 \" href=\"UTD.htm?28/51/29489\">",
"       figure 1",
"      </a>",
"      ). However, if patients have normal ventricular function and oxygen saturation, they may be allowed to participate in class IB sports.",
"     </li>",
"     <li>",
"      Patients with congenital artery anomalies are allowed to participate in all sports following successful operation if the patient does not have ischemia, ventricular tachyarrhythmias, or dysfunction. However, patients with persistent coronary anomalies or ischemia should be restricted from participating in competitive sports [",
"      <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/87\">",
"       87",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363263318\">",
"    <span class=\"h2\">",
"     Endocarditis prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prophylactic antibiotics for endocarditis are recommended for all patients for six months after a complete repair, and beyond that for patients who have repairs that include the use of prosthetic material, a prior episode of endocarditis, and those with a residual intracardiac shunt who remain cyanotic or have patch leaks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363263605\">",
"    <span class=\"h2\">",
"     Vaccination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with",
"    <span class=\"nowrap\">",
"     PA/IVS",
"    </span>",
"    should receive all recommended vaccinations, including yearly influenza vaccines and pavlizumab for prophylaxis against respiratory syncytial virus in patients younger than two years of age with hemodynamically significant disease (",
"    <a class=\"graphic graphic_table graphicRef73126 \" href=\"UTD.htm?31/55/32635\">",
"     table 3",
"    </a>",
"    ). Vaccinations are usually administered six weeks after major cardiac procedures or surgery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=see_link&amp;anchor=H104282423#H104282423\">",
"     \"Respiratory syncytial virus infection: Prevention\", section on 'Congenital heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H363264985\">",
"    <span class=\"h2\">",
"     Pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful pregnancies have been reported in patients who have achieved biventricular repair [",
"    <a class=\"abstract\" href=\"UTD.htm?23/55/24442/abstract/88\">",
"     88",
"    </a>",
"    ]. A comprehensive cardiovascular evaluation by a congenital cardiac specialist is recommended prior to pregnancy to confirm there are no cardiovascular features that would be best treated before a pregnancy, or to suggest a pregnancy would be high risk and not advised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258049170\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary atresia with intact ventricular septum",
"    <span class=\"nowrap\">",
"     (PA/IVS)",
"    </span>",
"    is characterized by a complete obstruction to right ventricular outflow with varying degrees of right ventricular and tricuspid valve hypoplasia.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      accounts for 1 to 3 percent of all congenital heart defects with a reported incidence between four and eight per 100,000 live births. (See",
"      <a class=\"local\" href=\"#H172915282\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      is unknown. It has been proposed that",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      is an acquired lesion due to perturbation of fetal blood flow rather than a primary morphogenetic lesion. (See",
"      <a class=\"local\" href=\"#H258049037\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      consists of a wide variety of anatomical cardiac defects that typically consist of pulmonary valve atresia, varying degrees of hypoplasia of the right ventricle (RV) and tricuspid valve (TV), and in the majority of cases, abnormal connections between the RV and coronary arteries. (See",
"      <a class=\"local\" href=\"#H258049044\">",
"       'Anatomy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In",
"      <span class=\"nowrap\">",
"       PA/IVS,",
"      </span>",
"      pulmonary atresia causes right ventricular outflow tract (RVOT) obstruction. Because of the intact ventricular septum, blood can only exit the RV either back into the right atrium or through connections between the RV and the coronary artery circulation (ie, fistulae and sinusoids). Blood is returned to the systemic circulation from the right to left atrium through the patent foramen ovale and through the coronary circulation. (See",
"      <a class=\"local\" href=\"#H291329\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      present as neonates with cyanosis accompanied with mild tachypnea or hyperpnea. Because",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      is a ductal-dependent lesion, closure of the patent ductus arteriosus (PDA) generally results in rapid clinical deterioration and life-threatening consequences (eg, cardiogenic shock and cardiac arrest). If untreated,",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      is an almost uniformly fatal disease. (See",
"      <a class=\"local\" href=\"#H258049086\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Initial laboratory testing demonstrates hypoxemia by either pulse oximetry screening or arterial blood gas sampling (",
"      <a class=\"graphic graphic_table graphicRef75461 \" href=\"UTD.htm?10/61/11228\">",
"       table 1",
"      </a>",
"      ), unremarkable chest radiograph (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef88537 \" href=\"UTD.htm?13/21/13652\">",
"       image 1",
"      </a>",
"      ), and an electrocardiograph with characteristic findings of a QRS axis between 0 to +90 degrees and decreasing right-sided ventricular forces (",
"      <a class=\"graphic graphic_waveform graphicRef88539 \" href=\"UTD.htm?1/33/1561\">",
"       waveform 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H518117882\">",
"       'Laboratory testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       PV/IVS",
"      </span>",
"      is diagnosed by echocardiography with the identification of an atretic pulmonary valve and intact ventricular septum (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef88540 \" href=\"UTD.htm?21/61/22488\">",
"       image 2",
"      </a>",
"      ). In addition, echocardiography should evaluate the size and function of the RV and TV, and assess intracardiac mixing through the patent foramen ovale and pulmonary blood flow through the PDA. (See",
"      <a class=\"local\" href=\"#H518118043\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Cardiac catheterization is essential to identify coronary abnormalities, which is an important factor in the choice of repair (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef88541 \" href=\"UTD.htm?35/5/35926\">",
"       image 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H597292146\">",
"       'Cardiac catheterization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis includes other cyanotic congenital heart defects with RVOT, and is distinguished from these conditions by echocardiography. (See",
"      <a class=\"local\" href=\"#H597292183\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that all neonates with",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      be treated in a medical center with experience in managing complex congenital heart disease (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We recommend that all neonates be treated with the following management approach of initial stabilization and subsequent repair (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Initial stabilization includes general cardiorespiratory support and administration of prostaglandin E1 to maintain patency of the ductus arteriosus. (See",
"      <a class=\"local\" href=\"#H597292176\">",
"       'Initial stabilization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Options for subsequent repair include biventricular repair (separate pulmonary and systemic circulations with two pumping ventricles), univentricular repair (separate pulmonary and systemic circulation with one pumping ventricle), 1.5 ventricle hybrid repair (separate pulmonary and systemic circulations with two pumping ventricles, but with one source of pulmonary blood flow from the superior vena cava), and, rarely, cardiac transplantation. The choice of repair is based on the assessment of the feasibility of biventricular repair, which depends on the morphologic features of the individual patient (eg, RV and TV size and function, and coronary artery circulation). (See",
"      <a class=\"local\" href=\"#H27930387\">",
"       'Repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The current overall five-year survival rate for patients with",
"      <span class=\"nowrap\">",
"       PA/IVS",
"      </span>",
"      is about 80 percent, and is reported to be greater than 90 percent in patients in whom biventricular repair is feasible. (See",
"      <a class=\"local\" href=\"#H258049121\">",
"       'Survival'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Providing health care maintenance is a collaborative effort between primary care and pediatric cardiology clinicians. Follow-up care consists of routine visits that include history, physical examination, and cardiac testing (electrocardiography and echocardiography) that are focused on identifying patients with complications following repair such as heart failure and arrhythmias, and in patients with univentricular repair, identifying evidence of increasing cyanosis or cardiac ischemia. (See",
"      <a class=\"local\" href=\"#H258049156\">",
"       'Health care maintenance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/1\">",
"      Report of the New England Regional Infant Cardiac Program. Pediatrics 1980; 65:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/2\">",
"      Ferencz C, Rubin JD, McCarter RJ, et al. Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol 1985; 121:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/3\">",
"      Hanley FL, Sade RM, Blackstone EH, et al. Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study. J Thorac Cardiovasc Surg 1993; 105:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/4\">",
"      Ashburn DA, Blackstone EH, Wells WJ, et al. Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg 2004; 127:1000.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/5\">",
"      Dyamenahalli U, McCrindle BW, McDonald C, et al. Pulmonary atresia with intact ventricular septum: management of, and outcomes for, a cohort of 210 consecutive patients. Cardiol Young 2004; 14:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/6\">",
"      Ekman Joelsson BM, Sunneg&aring;rdh J, Hanseus K, et al. The outcome of children born with pulmonary atresia and intact ventricular septum in Sweden from 1980 to 1999. Scand Cardiovasc J 2001; 35:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/7\">",
"      Daubeney PE, Delany DJ, Anderson RH, et al. Pulmonary atresia with intact ventricular septum: range of morphology in a population-based study. J Am Coll Cardiol 2002; 39:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/8\">",
"      Sam&aacute;nek M, Vor&iacute;skov&aacute; M. Congenital heart disease among 815,569 children born between 1980 and 1990 and their 15-year survival: a prospective Bohemia survival study. Pediatr Cardiol 1999; 20:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/9\">",
"      Tuo G, Volpe P, Bondanza S, et al. Impact of prenatal diagnosis on outcome of pulmonary atresia and intact ventricular septum. J Matern Fetal Neonatal Med 2012; 25:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/10\">",
"      Daubeney PE, Sharland GK, Cook AC, et al. Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum. Circulation 1998; 98:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/11\">",
"      Chitayat D, McIntosh N, Fouron JC. Pulmonary atresia with intact ventricular septum and hypoplastic right heart in sibs: a single gene disorder? Am J Med Genet 1992; 42:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/12\">",
"      Grossfeld PD, Lucas VW, Sklansky MS, et al. Familial occurrence of pulmonary atresia with intact ventricular septum. Am J Med Genet 1997; 72:294.",
"     </a>",
"    </li>",
"    <li>",
"     Rudolph AM. Congenital diseases of the heart: clinical-physiological considerations, Wiley-Blackwell, Hoboken, NJ 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/14\">",
"      Gardiner HM. Progression of fetal heart disease and rationale for fetal intracardiac interventions. Semin Fetal Neonatal Med 2005; 10:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/15\">",
"      Kutsche LM, Van Mierop LH. Pulmonary atresia with and without ventricular septal defect: a different etiology and pathogenesis for the atresia in the 2 types? Am J Cardiol 1983; 51:932.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/16\">",
"      Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115:2995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/17\">",
"      Botto LD, Lynberg MC, Erickson JD. Congenital heart defects, maternal febrile illness, and multivitamin use: a population-based study. Epidemiology 2001; 12:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/18\">",
"      Lacour-Gayet F. Congenital Heart Surgery Nomenclature and Database Project: right ventricular outflow tract obstruction-intact ventricular septum. Ann Thorac Surg 2000; 69:S83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/19\">",
"      Braunlin EA, Formanek AG, Moller JH, Edwards JE. Angio-pathological appearances of pulmonary valve in pulmonary atresia with intact ventricular septum. Interpretation of nature of right ventricle from pulmonary angiography. Br Heart J 1982; 47:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/20\">",
"      Kipps AK, Powell AJ, Levine JC. Muscular infundibular atresia is associated with coronary ostial atresia in pulmonary atresia with intact ventricular septum. Congenit Heart Dis 2011; 6:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/21\">",
"      Anderson RH, Spicer D. Fistulous communications with the coronary arteries in the setting of hypoplastic ventricles. Cardiol Young 2010; 20 Suppl 3:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/22\">",
"      Calder AL, Co EE, Sage MD. Coronary arterial abnormalities in pulmonary atresia with intact ventricular septum. Am J Cardiol 1987; 59:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/23\">",
"      Freedom RM, Anderson RH, Perrin D. The significance of ventriculo-coronary arterial connections in the setting of pulmonary atresia with an intact ventricular septum. Cardiol Young 2005; 15:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/24\">",
"      Calder AL, Peebles CR, Occleshaw CJ. The prevalence of coronary arterial abnormalities in pulmonary atresia with intact ventricular septum and their influence on surgical results. Cardiol Young 2007; 17:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/25\">",
"      Giglia TM, Jenkins KJ, Matitiau A, et al. Influence of right heart size on outcome in pulmonary atresia with intact ventricular septum. Circulation 1993; 88:2248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/26\">",
"      Satou GM, Perry SB, Gauvreau K, Geva T. Echocardiographic predictors of coronary artery pathology in pulmonary atresia with intact ventricular septum. Am J Cardiol 2000; 85:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/27\">",
"      Giglia TM, Mandell VS, Connor AR, et al. Diagnosis and management of right ventricle-dependent coronary circulation in pulmonary atresia with intact ventricular septum. Circulation 1992; 86:1516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/28\">",
"      Mainwaring RD, Sheikh AY, Punn R, et al. Surgical outcomes for patients with pulmonary atresia/major aortopulmonary collaterals and Alagille syndrome. Eur J Cardiothorac Surg 2012; 42:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/29\">",
"      Tanaka T, Yamaki S, Kakizawa H. Histologic study of the small pulmonary arteries in 38 patients with pulmonary atresia and intact ventricular septum. Jpn Circ J 1996; 60:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/30\">",
"      Miyaji K, Murakami A, Takasaki T, et al. Does a bidirectional Glenn shunt improve the oxygenation of right ventricle-dependent coronary circulation in pulmonary atresia with intact ventricular septum? J Thorac Cardiovasc Surg 2005; 130:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/31\">",
"      Shinebourne EA, Rigby ML, Carvalho JS. Pulmonary atresia with intact ventricular septum: from fetus to adult: congenital heart disease. Heart 2008; 94:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/32\">",
"      Leonard H, Derrick G, O'Sullivan J, Wren C. Natural and unnatural history of pulmonary atresia. Heart 2000; 84:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/33\">",
"      McArthur JD, Munsi SC, Sukumar IP, Cherian G. Pulmonary valve atresia with intact ventricular septum. Report of a case with long survival and pulmonary blood supply from an anomalous coronary artery. Circulation 1971; 44:740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/34\">",
"      Fyfe DA, Edwards WD, Driscoll DJ. Myocardial ischemia in patients with pulmonary atresia and intact ventricular septum. J Am Coll Cardiol 1986; 8:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/35\">",
"      Sandor GG, Cook AC, Sharland GK, et al. Coronary arterial abnormalities in pulmonary atresia with intact ventricular septum diagnosed during fetal life. Cardiol Young 2002; 12:436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/36\">",
"      Emmel M, Bald R, Brockmeier K. Pulmonary atresia with intact ventricular septum and right coronary artery to right ventricle fistula detected in utero. Heart 2004; 90:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/37\">",
"      Salvin JW, McElhinney DB, Colan SD, et al. Fetal tricuspid valve size and growth as predictors of outcome in pulmonary atresia with intact ventricular septum. Pediatrics 2006; 118:e415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/38\">",
"      Iacobelli R, Pasquini L, Toscano A, et al. Role of tricuspid regurgitation in fetal echocardiographic diagnosis of pulmonary atresia with intact ventricular septum. Ultrasound Obstet Gynecol 2008; 32:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/39\">",
"      Peterson RE, Levi DS, Williams RJ, et al. Echocardiographic predictors of outcome in fetuses with pulmonary atresia with intact ventricular septum. J Am Soc Echocardiogr 2006; 19:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/40\">",
"      Kawazu Y, Inamura N, Kayatani F. Prediction of therapeutic strategy and outcome for antenatally diagnosed pulmonary atresia/stenosis with intact ventricular septum. Circ J 2008; 72:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/41\">",
"      Roman KS, Fouron JC, Nii M, et al. Determinants of outcome in fetal pulmonary valve stenosis or atresia with intact ventricular septum. Am J Cardiol 2007; 99:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/42\">",
"      Gardiner HM, Belmar C, Tulzer G, et al. Morphologic and functional predictors of eventual circulation in the fetus with pulmonary atresia or critical pulmonary stenosis with intact septum. J Am Coll Cardiol 2008; 51:1299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/43\">",
"      Odim J, Laks H, Tung T. Risk factors for early death and reoperation following biventricular repair of pulmonary atresia with intact ventricular septum. Eur J Cardiothorac Surg 2006; 29:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/44\">",
"      Li S, Chen W, Zhang Y, et al. Hybrid therapy for pulmonary atresia with intact ventricular septum. Ann Thorac Surg 2011; 91:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/45\">",
"      Liava'a M, Brooks P, Konstantinov I, et al. Changing trends in the management of pulmonary atresia with intact ventricular septum: the Melbourne experience. Eur J Cardiothorac Surg 2011; 40:1406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/46\">",
"      Minich LL, Tani LY, Ritter S, et al. Usefulness of the preoperative tricuspid/mitral valve ratio for predicting outcome in pulmonary atresia with intact ventricular septum. Am J Cardiol 2000; 85:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/47\">",
"      Cleuziou J, Schreiber C, Eicken A, et al. Predictors for biventricular repair in pulmonary atresia with intact ventricular septum. Thorac Cardiovasc Surg 2010; 58:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/48\">",
"      Yoshimura N, Yamaguchi M, Ohashi H, et al. Pulmonary atresia with intact ventricular septum: strategy based on right ventricular morphology. J Thorac Cardiovasc Surg 2003; 126:1417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/49\">",
"      Guleserian KJ, Armsby LB, Thiagarajan RR, et al. Natural history of pulmonary atresia with intact ventricular septum and right-ventricle-dependent coronary circulation managed by the single-ventricle approach. Ann Thorac Surg 2006; 81:2250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/50\">",
"      Mainwaring RD, Lamberti JJ. Pulmonary atresia with intact ventricular septum. Surgical approach based on ventricular size and coronary anatomy. J Thorac Cardiovasc Surg 1993; 106:733.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/51\">",
"      Daubeney PE, Wang D, Delany DJ, et al. Pulmonary atresia with intact ventricular septum: predictors of early and medium-term outcome in a population-based study. J Thorac Cardiovasc Surg 2005; 130:1071.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/52\">",
"      Kreutzer C, Mayorquim RC, Kreutzer GO, et al. Experience with one and a half ventricle repair. J Thorac Cardiovasc Surg 1999; 117:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/53\">",
"      Maluf MA, Carvalho AC, Carvalho WB. One and a half ventricular repair as an alternative for hypoplastic right ventricle. Rev Bras Cir Cardiovasc 2010; 25:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/54\">",
"      Stellin G, Vida VL, Milanesi O, et al. Surgical treatment of complex cardiac anomalies: the 'one and one half ventricle repair'. Eur J Cardiothorac Surg 2002; 22:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/55\">",
"      Yoshimura N, Yamaguchi M. Surgical strategy for pulmonary atresia with intact ventricular septum: initial management and definitive surgery. Gen Thorac Cardiovasc Surg 2009; 57:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/56\">",
"      Hannan RL, Zabinsky JA, Stanfill RM, et al. Midterm results for collaborative treatment of pulmonary atresia with intact ventricular septum. Ann Thorac Surg 2009; 87:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/57\">",
"      Burke RP, Hannan RL, Zabinsky JA, et al. Hybrid ventricular decompression in pulmonary atresia with intact septum. Ann Thorac Surg 2009; 88:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/58\">",
"      Huang SC, Ishino K, Kasahara S, et al. The potential of disproportionate growth of tricuspid valve after decompression of the right ventricle in patients with pulmonary atresia and intact ventricular septa. J Thorac Cardiovasc Surg 2009; 138:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/59\">",
"      Chubb H, Pesonen E, Sivasubramanian S, et al. Long-term outcome following catheter valvotomy for pulmonary atresia with intact ventricular septum. J Am Coll Cardiol 2012; 59:1468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/60\">",
"      Hasan BS, Bautista-Hernandez V, McElhinney DB, et al. Outcomes of transcatheter approach for initial treatment of pulmonary atresia with intact ventricular septum. Catheter Cardiovasc Interv 2013; 81:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/61\">",
"      Hirata Y, Chen JM, Quaegebeur JM, et al. Pulmonary atresia with intact ventricular septum: limitations of catheter-based intervention. Ann Thorac Surg 2007; 84:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/62\">",
"      McLean KM, Pearl JM. Pulmonary atresia with intact ventricular septum: initial management. Ann Thorac Surg 2006; 82:2214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/63\">",
"      Marasini M, Gorrieri PF, Tuo G, et al. Long-term results of catheter-based treatment of pulmonary atresia and intact ventricular septum. Heart 2009; 95:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/64\">",
"      Tworetzky W, McElhinney DB, Marx GR, et al. In utero valvuloplasty for pulmonary atresia with hypoplastic right ventricle: techniques and outcomes. Pediatrics 2009; 124:e510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/65\">",
"      Tulzer G, Arzt W, Franklin RC, et al. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 2002; 360:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/66\">",
"      Huhta J, Quintero RA, Suh E, Bader R. Advances in fetal cardiac intervention. Curr Opin Pediatr 2004; 16:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/67\">",
"      Hoashi T, Kagisaki K, Kitano M, et al. Late clinical features of patients with pulmonary atresia or critical pulmonary stenosis with intact ventricular septum after biventricular repair. Ann Thorac Surg 2012; 94:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/68\">",
"      Bautista-Hernandez V, Hasan BS, Harrild DM, et al. Late pulmonary valve replacement in patients with pulmonary atresia and intact ventricular septum: a case-matched study. Ann Thorac Surg 2011; 91:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/69\">",
"      Powell AJ, Mayer JE, Lang P, Lock JE. Outcome in infants with pulmonary atresia, intact ventricular septum, and right ventricle-dependent coronary circulation. Am J Cardiol 2000; 86:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/70\">",
"      Najm HK, Williams WG, Coles JG, et al. Pulmonary atresia with intact ventricular septum: results of the Fontan procedure. Ann Thorac Surg 1997; 63:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/71\">",
"      Mair DD, Julsrud PR, Puga FJ, Danielson GK. The Fontan procedure for pulmonary atresia with intact ventricular septum: operative and late results. J Am Coll Cardiol 1997; 29:1359.",
"     </a>",
"    </li>",
"    <li>",
"     Karamlou T, Poynter JA, et al. Long-term functional health status and exercise test variables for patients with pulmonary atresia with intact ventricular septum: A Congenital Heart Surgeons Society study. Read at the 92nd Annual Meeting of The American Association for Thoracic Surgery, San Francisco, California, April 28-May 2, 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/73\">",
"      Ekman-Joelsson BM, Berntsson L, Sunneg&aring;rdh J. Quality of life in children with pulmonary atresia and intact ventricular septum. Cardiol Young 2004; 14:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/74\">",
"      Ekman-Joelsson BM, Gustafsson PM, Sunneg&aring;rdh J. Exercise performance after surgery for pulmonary atresia and intact ventricular septum. Pediatr Cardiol 2009; 30:752.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/75\">",
"      Romeih S, Groenink M, van der Plas MN, et al. Effect of age on exercise capacity and cardiac reserve in patients with pulmonary atresia with intact ventricular septum after biventricular repair. Eur J Cardiothorac Surg 2012; 42:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/76\">",
"      Romeih S, Groenink M, Roest AA, et al. Exercise capacity and cardiac reserve in children and adolescents with corrected pulmonary atresia with intact ventricular septum after univentricular palliation and biventricular repair. J Thorac Cardiovasc Surg 2012; 143:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/77\">",
"      Sanghavi DM, Flanagan M, Powell AJ, et al. Determinants of exercise function following univentricular versus biventricular repair for pulmonary atresia/intact ventricular septum. Am J Cardiol 2006; 97:1638.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/78\">",
"      Numata S, Uemura H, Yagihara T, et al. Long-term functional results of the one and one half ventricular repair for the spectrum of patients with pulmonary atresia/stenosis with intact ventricular septum. Eur J Cardiothorac Surg 2003; 24:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/79\">",
"      Sananes R, Manlhiot C, Kelly E, et al. Neurodevelopmental outcomes after open heart operations before 3 months of age. Ann Thorac Surg 2012; 93:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/80\">",
"      Newburger JW, Sleeper LA, Bellinger DC, et al. Early developmental outcome in children with hypoplastic left heart syndrome and related anomalies: the single ventricle reconstruction trial. Circulation 2012; 125:2081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/81\">",
"      Soto CB, Olude O, Hoffmann RG, et al. Implementation of a routine developmental follow-up program for children with congenital heart disease: early results. Congenit Heart Dis 2011; 6:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/82\">",
"      Wypij D, Newburger JW, Rappaport LA, et al. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston Circulatory Arrest Trial. J Thorac Cardiovasc Surg 2003; 126:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/83\">",
"      Wernovsky G, Rome JJ, Tabbutt S, et al. Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis 2006; 1:10.",
"     </a>",
"    </li>",
"    <li>",
"     Naqvi N, Daubeney PEF. Pulmonary atresia with intact ventricular septum. In: Diagnosis and Management of Adult Congenital Heart Disease, 2nd ed, Gatzoulis MA, Webb GD, Daubeney PEF (Eds), Elsevier Saunders, Philadelphia 2011. p.339.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/85\">",
"      Graham TP Jr, Driscoll DJ, Gersony WM, et al. Task Force 2: congenital heart disease. J Am Coll Cardiol 2005; 45:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/86\">",
"      Pelliccia A, Fagard R, Bj&oslash;rnstad HH, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:1422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/87\">",
"      Thompson PD, Balady GJ, Chaitman BR, et al. Task Force 6: coronary artery disease. J Am Coll Cardiol 2005; 45:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?23/55/24442/abstract/88\">",
"      Drenthen W, Pieper PG, Zoon N, et al. Pregnancy after biventricular repair for pulmonary atresia with ventricular septal defect. Am J Cardiol 2006; 98:262.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 87462 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.80.101-E34D2EC933-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24442=[""].join("\n");
var outline_f23_55_24442=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H258049170\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049009\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049016\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H172915282\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049037\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049044\">",
"      ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258049051\">",
"      Pulmonary valve atresia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518116564\">",
"      Right ventricle",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258049058\">",
"      Tricuspid valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258049065\">",
"      Coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518116525\">",
"      Pulmonary circulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H535752701\">",
"      Other anatomic features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H535752708\">",
"      - Left ventricle and aortic valve",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H535752715\">",
"      - Right atrium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H291329\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049086\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518116982\">",
"      Fetal presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518117018\">",
"      Postnatal presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H518118023\">",
"      - Physical findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H518117107\">",
"      - Tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H518117137\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H518117152\">",
"      Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H518117159\">",
"      Electrocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H518117882\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H518118043\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518118050\">",
"      Fetal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H518118251\">",
"      Postnatal diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H597292087\">",
"      - Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597292094\">",
"      FURTHER EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H597292101\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H597292146\">",
"      Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H597292183\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049093\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H597292169\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H597292176\">",
"      Initial stabilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27930387\">",
"      Repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H121819659\">",
"      - Our approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258049107\">",
"      Fetal intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049114\">",
"      OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258049121\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H363262645\">",
"      - Biventricular repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258049128\">",
"      - Univentricular repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H363262857\">",
"      - Hybrid repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258049149\">",
"      Quality of life",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049156\">",
"      HEALTH CARE MAINTENANCE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H363263346\">",
"      Activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H363263318\">",
"      Endocarditis prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H363263605\">",
"      Vaccination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H363264985\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258049170\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/87462\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/87462|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/21/13652\" title=\"diagnostic image 1\">",
"      Chest x-ray pulmonary atresia with intact VS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?21/61/22488\" title=\"diagnostic image 2\">",
"      Echo pulmonary atresia with intact VS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/5/35926\" title=\"diagnostic image 3\">",
"      Cath pulmonary atresia with intact VS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/87462|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/51/29489\" title=\"figure 1\">",
"      Classification exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/87462|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/61/11228\" title=\"table 1\">",
"      PaO2 in cyanotic heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/41/17053\" title=\"table 2\">",
"      Interpretation neonatal hyperoxia test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/55/32635\" title=\"table 3\">",
"      RSV prophylaxis and CHD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/87462|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?1/33/1561\" title=\"waveform 1\">",
"      ECG pulmonary atresia with intact VS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/44/33482?source=related_link\">",
"      Congenital heart disease (CHD) in the newborn: Presentation and screening for critical CHD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=related_link\">",
"      Diagnosis and initial management of cyanotic heart disease in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/52/38729?source=related_link\">",
"      Ebstein's anomaly of the tricuspid valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/27/41401?source=related_link\">",
"      Hypoplastic left heart syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/27/13752?source=related_link\">",
"      Pathophysiology, clinical features, and diagnosis of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/17/15640?source=related_link\">",
"      Respiratory syncytial virus infection: Prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f23_55_24443="Disorders that affect TSH";
var content_f23_55_24443=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F68907&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F68907&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Disorders that affect serum TSH concentrations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Low serum TSH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Incomplete recovery from hyperthyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonthyroidal illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High levels of chorionic gonadotropin - early pregnancy, molar pregnancy, choriocarcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drugs - dopamine agonists, glucocorticoids, somatostatin analogs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Central hypothyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        High serum TSH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary hypothyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recovery from nonthyroidal illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Drugs - dopamine antagonists, amiodarone, oral cholecystogram dye (sodium ipodate)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TSH-producing pituitary adenoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Adrenal insufficiency",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Heterophilic antibody interference",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Generalized thyroid hormone resistance",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24443=[""].join("\n");
var outline_f23_55_24443=null;
var title_f23_55_24444="Diagnostic evaluation fever and neutropenia";
var content_f23_55_24444=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F50509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F50509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic evaluation of patients with fever and neutropenia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"33%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Item",
"       </td>",
"       <td class=\"subtitle1\">",
"        Purpose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Targeted history",
"       </td>",
"       <td>",
"        Seek sites suspicious for infection",
"       </td>",
"       <td>",
"        Allows detection of symptoms of infection",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Physical exam with emphasis on skin, oral cavity, oropharynx, lungs, abdomen, perianal area*",
"       </td>",
"       <td>",
"        Detection of sites suspicious for infection; guides selection of cultures and imaging",
"       </td>",
"       <td>",
"        Pain and/or erythema may point to infection; pus is not found due to lack of neutrophils; chest exam may be unremarkable even with pneumonia; abdominal tenderness may suggest neutropenic enterocolitis; perianal or hemorrhoidal tenderness may point to gram-negative or anaerobic infection",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Complete blood count with differential",
"       </td>",
"       <td>",
"        Defines the depth of neutropenia",
"       </td>",
"       <td>",
"        The lower the initial neutrophil count, the greater the likelihood of serious infection or bacteremia; daily counts allow prognostication",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Creatinine, liver function tests, electrolytes",
"       </td>",
"       <td>",
"        Defines comorbid conditions",
"       </td>",
"       <td>",
"        Allows optimal selection and dose of antimicrobial agent(s) and serial monitoring of toxicities",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Blood cultures (2 sets, one peripheral and one from central venous catheter); antimicrobial susceptibility testing",
"       </td>",
"       <td>",
"        Detection of bacteremia",
"       </td>",
"       <td>",
"        Fever may be the only sign of bacteremia; allows adjustment of antibiotic regimen if necessary",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Cultures and stains of samples from suspected sites of infection",
"       </td>",
"       <td>",
"        Detection of infectious etiology",
"       </td>",
"       <td>",
"        Bacterial and fungal stains can be helpful",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Imaging studies (generally recommended only if site is suspected from history or exam)",
"       </td>",
"       <td>",
"        Detection of infectious site",
"       </td>",
"       <td>",
"        Computed tomography (CT) scans are generally more useful than plain radiographs; pulmonary infiltrates may be inapparent by plain radiography during deep neutropenia and may become manifest only upon neutrophil recovery; thickened bowel walls are seen by CT scan with neutropenic enterocolitis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Digital rectal examination is avoided in neutropenic patients.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24444=[""].join("\n");
var outline_f23_55_24444=null;
var title_f23_55_24445="Pathophysiology of MAS";
var content_f23_55_24445=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathophysiology of meconium aspiration syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 331px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph A Garcia-Prats, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24445=[""].join("\n");
var outline_f23_55_24445=null;
var title_f23_55_24446="Achalasia barium swallow";
var content_f23_55_24446=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F53672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F53672&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Achalasia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 230px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Barium swallow showing a dilated esophagus and birds beak appearance typical of achalasia. Retained food is also visible.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Ram Dickman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24446=[""].join("\n");
var outline_f23_55_24446=null;
var title_f23_55_24447="ECG strip WPW concertina effect";
var content_f23_55_24447=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F65293&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F65293&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 484px\">",
"   <div class=\"ttl\">",
"    Single-lead electrocardiogram (ECG) strip showing concertina effect in Wolff-Parkinson-White syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 464px; height: 111px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Single channel rhythm strip from a patient with the Wolff-Parkinson-White syndrome shows progressive shortening of the PR interval with the development of a widened QRS complex due to a delta wave. The P wave appears to merge with the QRS complex (arrows). The last two QRS complexes again show a normal PR interval and a narrow QRS complex.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f23_55_24447=[""].join("\n");
var outline_f23_55_24447=null;
